{"Row Number": 353, "Calculator Name": "HAS-BLED Score for Major Bleeding Risk", "Calculator ID": "25", "Category": "risk", "Note ID": "10", "Patient Note": "A 72-year-old man finds himself back at the primary care clinic for his routine visit. His well-documented history of uncontrolled hypertension is a notable element in his case file. However, there is no suggestion of a previous stroke episode. He admits to patronizing alcohol, averaging 9 drinks per week. Also noteworthy in his medical history are his liver and renal conditions. On the one hand, he has had numerous hospital admissions over the years with repeated indications of hepatic impairment due to ALD. His renal function has also been a concern, as demonstrated by an elevated creatinine and reduced glomerular filtration rate. Contrarily, when it comes to bleeding risk, he has never been prescribed any medication known to accelerate bleeding. His coagulation profiles are quite stable, demonstrated by a consistently normal international normalized ratio (INR). These medical intricacies necessitate a comprehensive, focused approach to his healthcare management.", "Question": "What is the patient's HAS-BLED score?", "LLM Name": "BytedTsinghua-SIA/DAPO-Qwen-32B", "LLM Answer": "4", "LLM Explanation": "To calculate the HAS-BLED score for this patient, we will evaluate each component of the HAS-BLED score based on the information provided in the patient note. Here's the breakdown: - **H (Hypertension):** The patient has uncontrolled hypertension. This gives 1 point. - **A (Age \u2265 65):** The patient is 72 years old, which is over 65. This gives 1 point. - **S (Serum creatinine > upper limit of normal or renal impairment):** The note mentions that the patient has renal impairment with elevated creatinine and reduced GFR. This indicates renal impairment, so this gives 1 point. - **B (Bleeding history or peptic ulcer disease):** There is no mention of a previous bleeding history or peptic ulcer disease. Therefore, this gives 0 points. - **L (Liver disease):** The patient has hepatic impairment due to ALD (alcoholic liver disease). This indicates liver disease, so this gives 1 point. - **E (Labile INR):** The note states that the patient's coagulation profiles are stable, with a consistently normal INR. Therefore, there is no labile INR, so this gives 0 points. - **D (Concomitant use of drugs that increase bleeding risk, such as NSAIDs, antiplatelets, or anticoagulants):** The note says the patient has never been prescribed any medication known to accelerate bleeding. Therefore, this gives 0 points. Now, let's sum up the points from each component: - H = 1 - A = 1 - S = 1 - B = 0 - L = 1 - E = 0 - D = 0 Adding these up: 1 + 1 + 1 + 0 + 1 + 0 + 0 = 4 Therefore, the HAS-BLED score for this patient is 4.", "LLM Thinking": "Okay, I need to calculate the HAS-BLED score for this patient. Let me remember what the HAS-BLED score is. From what I recall, HAS-BLED is a tool used to assess the risk of bleeding in patients, often those with atrial fibrillation who might be considered for anticoagulation. The acronym stands for H, A, S, B, L, E, D. Each letter corresponds to a factor that contributes to bleeding risk. Each component is scored as 1 if present and 0 if not, so the total score ranges from 0 to 9. The higher the score, the higher the bleeding risk. Let me break down each component: H stands for Hypertension. That's controlled or uncontrolled? The note says his hypertension is uncontrolled. So that's a point. A is Age \u226565. The patient is 72, which is over 65, so that's another point. S is Serum creatinine > upper limit of normal. The note mentions he has renal impairment with elevated creatinine and reduced GFR. So yes, that's a point. B is Bleeding history. The patient has no history of previous stroke, but the question is about bleeding, not stroke. Wait, the note says \"no suggestion of a previous stroke episode.\" So maybe no history of stroke, but does he have a history of other bleeding events? The note doesn't mention any past bleeds. Hmm. So B would be 0 here. L is Liver disease. The patient has hepatic impairment due to ALD (alcoholic liver disease). So that's a point. E is Electrolyte abnormalities. The note mentions his coagulation profiles are stable, INR normal. But the E component in HAS-BLED is about electrolyte abnormalities. The note doesn't mention anything about electrolytes like potassium or calcium being abnormal, so maybe this is 0. D is Drugs (anticoagulants, antiplatelets, NSAIDs, etc.). The patient is consuming alcohol at 9 drinks per week. Does that count as a drug here? The D component in HAS-BLED refers to drugs that increase bleeding risk. The note says he has never been prescribed medications that accelerate bleeding, but alcohol itself can increase bleeding risk. Wait, but does the D component specifically refer to medications like NSAIDs, aspirin, or anticoagulants, or does alcohol count? Let me check. The original HAS-BLED criteria: the D component is \"Drug use (e.g., NSAIDs, aspirin, warfarin)\" but also includes alcohol abuse. Wait, maybe I need to confirm. Alternatively, maybe the components are: Wait, let me recall the exact components of HAS-BLED: Hypertension Age \u226565 years Serum creatinine >1.3 mg/dL (or renal impairment) Bleeding history (previous gastrointestinal bleed, or other) or history of peptic ulcer disease Labile INR (if on anticoagulant therapy) Liver disease (elevated LFTs or cirrhosis) Drugs (NSAIDs, aspirin, warfarin, etc.) So D is Drugs, including NSAIDs, antiplatelets, etc. The patient is taking alcohol, but the question is whether alcohol counts as a drug here. In some versions, the D component is NSAIDs or antiplatelet use. The patient's note says he averages 9 drinks per week. If alcohol is considered a drug in the context of increasing bleeding risk, then that would contribute to the D score. But I need to verify. Alternatively, maybe the D component is about medications that are known to increase bleeding risk. The note states he has never been prescribed any medication known to accelerate bleeding. So perhaps he's not on NSAIDs or aspirin. However, his alcohol consumption might not be captured in the D component unless it\u2019s considered a drug. Wait, the original HAS-BLED criteria for D is \"concomitant use of drugs such as NSAIDs, antiplatelet agents, anticoagulants, or glucocorticoids\". Alcohol is not listed here. So maybe in this case, the D component is 0 because he's not on any of those drugs. However, the note mentions he has a history of ALD (alcoholic liver disease), so his alcohol use is part of the liver disease, but for the D component, it's about medications, not alcohol consumption. Therefore, D would be 0. Putting it all together: H: 1 (uncontrolled HTN) A: 1 (age 72) S: 1 (elevated creatinine, renal impairment) B: 0 (no bleeding history mentioned) L: 1 (liver disease from ALD) E: 0 (labile INR not present) D: 0 (no medications that increase bleeding risk as per note) Wait, let me check again: H: Uncontrolled hypertension \u2192 1 A: Age 72 \u2192 1 S: Renal impairment (elevated creatinine, reduced GFR) \u2192 1 B: No bleeding history \u2192 0 L: Liver disease (ALD) \u2192 1 E: Labile INR? The note says INR is consistently normal \u2192 so E is 0 D: No drugs that increase bleeding risk \u2192 0 Wait, but the note mentions that he has hepatic impairment due to ALD, so L is definitely 1. The E component is about labile INR. Since his INR is normal and stable, E is 0.", "Ground Truth Answer": "5", "Ground Truth Explanation": "The current HAS-BLED score is 0.\nThe patient is 72.0 years old. Because the patient's age is greater than 65 years, we increment the score by 1, making the current score 0 + 1 = 1.\nThe patient has 9 drinks a week. Because the patient has at least 8 alcoholic drinks a week, we increment the score by 1, making the current score 1 + 1 = 2.\nThe issue, hypertension, is reported to be present for the patient note and so we increase the score by 1, making the current score 2 + 1 = 3.\nThe issue, liver disease, is reported to be present for the patient note and so we increase the score by 1, making the current score 3 + 1 = 4.\nThe issue, renal disease, is reported to be present for the patient note and so we increase the score by 1, making the current score 4 + 1 = 5.\nThe issue, stroke history, is reported to be absent for the patient and so we do not change the score, keeping the current score at 5.\nThe issue, prior bleeding, is missing from the patient note and so we assume it to be absent and so we do not change the score, keeping the current score at 5.\nThe issue, labile inr, is reported to be absent for the patient and so we do not change the score, keeping the current score at 5.\nThe issue, medications for bleeding, is reported to be absent for the patient and so we do not change the score, keeping the current score at 5.\nHence, the patient's HAS-BLED score is 5.", "Result": "Incorrect", "Thought Type": "ensembled_thought_without_answer", "Transferred Thoughts": "Okay, I need to calculate the HAS-BLED score for this patient.  \nLet me remember what the HAS-BLED score is.  \nFrom what I recall, HAS-BLED is a tool used to assess the risk of bleeding in patients, often those with atrial fibrillation who might be considered for anticoagulation.  \nThe acronym stands for H, A, S, B, L, E, D.  \nEach letter corresponds to a factor that contributes to bleeding risk.  \nEach component is scored as 1 if present and 0 if not, so the total score ranges from 0 to 9.  \nThe higher the score, the higher the bleeding risk.\n\nLet me break down each component:  \nH stands for Hypertension.  \nThat's controlled or uncontrolled?  \nThe note says his hypertension is uncontrolled.  \nSo that's a point.  \nA is Age \u226565.  \nThe patient is 72, which is over 65, so that's another point.  \nS is Serum creatinine > upper limit of normal.  \nThe note mentions he has renal impairment with elevated creatinine and reduced GFR.  \nSo yes, that's a point.  \nB is Bleeding history.  \nThe patient has no history of previous stroke, but the question is about bleeding, not stroke.  \nWait, the note says \"no suggestion of a previous stroke episode.\"  \nSo maybe no history of stroke, but does he have a history of other bleeding events?  \nThe note doesn't mention any past bleeds.  \nHmm.  \nSo B would be 0 here.  \nL is Liver disease.  \nThe patient has hepatic impairment due to ALD (alcoholic liver disease).  \nSo that's a point.  \nE is Electrolyte abnormalities.  \nThe note mentions his coagulation profiles are stable, INR normal.  \nBut the E component in HAS-BLED is about electrolyte abnormalities.  \nThe note doesn't mention anything about electrolytes like potassium or calcium being abnormal, so maybe this is 0.  \nD is Drugs (anticoagulants, antiplatelets, NSAIDs, etc.).  \nThe patient is consuming alcohol at 9 drinks per week.  \nDoes that count as a drug here?  \nThe D component in HAS-BLED refers to drugs that increase bleeding risk.  \nThe note says he has never been prescribed medications that accelerate bleeding, but alcohol itself can increase bleeding risk.  \nWait, but does the D component specifically refer to medications like NSAIDs, aspirin, or anticoagulants, or does alcohol count?  \nLet me check.  \nThe original HAS-BLED criteria: the D component is \"Drug use (e.g., NSAIDs, aspirin, warfarin)\" but also includes alcohol abuse.  \nWait, maybe I need to confirm. Alternatively, maybe the components are:\n\nWait, let me recall the exact components of HAS-BLED:\n\nHypertension  \nAge \u226565 years  \nSerum creatinine >1.3 mg/dL (or renal impairment)  \nBleeding history (previous gastrointestinal bleed, or other) or history of peptic ulcer disease  \nLabile INR (if on anticoagulant therapy)  \nLiver disease (elevated LFTs or cirrhosis)  \nDrugs (NSAIDs, aspirin, warfarin, etc.)\n\nSo D is Drugs, including NSAIDs, antiplatelets, etc.  \nThe patient is taking alcohol, but the question is whether alcohol counts as a drug here.  \nIn some versions, the D component is NSAIDs or antiplatelet use.  \nThe patient's note says he averages 9 drinks per week.  \nIf alcohol is considered a drug in the context of increasing bleeding risk, then that would contribute to the D score.  \nBut I need to verify. Alternatively, maybe the D component is about medications that are known to increase bleeding risk.  \nThe note states he has never been prescribed any medication known to accelerate bleeding.  \nSo perhaps he's not on NSAIDs or aspirin.  \nHowever, his alcohol consumption might not be captured in the D component unless it\u2019s considered a drug.  \nWait, the original HAS-BLED criteria for D is \"concomitant use of drugs such as NSAIDs, antiplatelet agents, anticoagulants, or glucocorticoids\".  \nAlcohol is not listed here.  \nSo maybe in this case, the D component is 0 because he's not on any of those drugs.  \nHowever, the note mentions he has a history of ALD (alcoholic liver disease), so his alcohol use is part of the liver disease, but for the D component, it's about medications, not alcohol consumption.  \nTherefore, D would be 0.\n\nPutting it all together:  \nH: 1 (uncontrolled HTN)  \nA: 1 (age 72)  \nS: 1 (elevated creatinine, renal impairment)  \nB: 0 (no bleeding history mentioned)  \nL: 1 (liver disease from ALD)  \nE: 0 (labile INR not present)  \nD: 0 (no medications that increase bleeding risk as per note)\n\nWait, let me check again:  \nH: Uncontrolled hypertension \u2192 1  \nA: Age 72 \u2192 1  \nS: Renal impairment (elevated creatinine, reduced GFR) \u2192 1  \nB: No bleeding history \u2192 0  \nL: Liver disease (ALD) \u2192 1  \nE: Labile INR? The note says INR is consistently normal \u2192 so E is 0  \nD: No drugs that increase bleeding risk \u2192 0\n\nWait, but the note mentions that he has hepatic impairment due to ALD, so L is definitely 1.  \nThe E component is about labile INR. Since his INR is normal and stable, E is 0."}
{"Row Number": 561, "Calculator Name": "Framingham Risk Score for Hard Coronary Heart Disease", "Calculator ID": "46", "Category": "lab", "Note ID": "pmc-4429202-1", "Patient Note": "A 50-year-old male presented to the emergency department with a three-day history of progressive retrosternal chest pain. His medical history was significant only for acute diverticulitis one year prior to current presentation and a 3-pack year smoking history. He had no history of diabetes, hypertension, or dyslipidemia. He denied personal or family history of cardiovascular diseases, hypercoagulable states, or bleeding disorders. A review of systems was negative for headache, visual disturbances, pruritus, easy bruising, or erythromelalgia.\nOn presentation, the patient's blood pressure was 131/83 mm Hg and heart rate was 84 beats/minute. He was in moderate distress due to pain. Auscultation of the lungs revealed clear breath sounds. Cardiac exam was unremarkable. No hepatosplenomegaly was detected on palpation. There was no erythema or rash on skin exam.\nThe patient's initial CBC revealed a hemoglobin of 14.6 g/dL, hematocrit 43.9%, WBC count 13,100/mm3, and platelet count 1,026,000/mm3. During his previous emergency department visit for acute diverticulitis, his platelet count was 976,000/mm3. This was felt to be reactive due to acute inflammation, and he was discharged on a course of oral antibiotics. He had no subsequent outpatient follow-up.\nAn electrocardiogram showed a normal sinus rhythm with T wave inversions in leads III and aVF (). His initial troponin I was 0.15 ng/mL. A repeat level 6 hours later increased to 2.83 ng/mL, suggesting cardiac ischemia. His LDL was 107 mg/dL, HDL 43 mg/dL, and triglycerides 98 mg/dL. His electrolytes, BUN and creatinine, and liver enzymes were within normal limits.\nThe patient was transferred to the coronary care unit with a diagnosis of NSTEMI. A cardiac catheterization revealed a thrombus in the right coronary artery (RCA) with a 60% stenosis and a TIMI Grade II flow (). No percutaneous coronary intervention (PCI) was performed due to a perceived high risk of complications, specifically distal embolization, given the high platelet count. The patient was treated with aspirin 81 mg daily, prasugrel 10 mg daily, enoxaparin 1 mg/kg every 12 hours, and hydroxyurea 1,000 mg every 12 hours. Four days later, a repeat cardiac catheterization showed normal coronaries with dissolution of the previously found RCA thrombus and no underlying atherosclerotic plaques ().\nA peripheral blood smear was significant for marked thrombocytosis without an increase in immature myeloid elements. Molecular studies were negative for JAK2 mutations in V617F and exon 12 and positive for a CALR mutation type 1 (del52). Testing for BCR/ABL translocations was negative. Hence, a diagnosis of ET was made on the basis of the clinical presentation, consistently high platelet count, and presence of a clonal marker.\nThe patient was discharged home in stable condition on hydroxyurea and low-dose aspirin. His platelet count on discharge was 821,000/mm3. Two months later, his platelet count normalized to 320,000/mm3. He continued to do well with no further thrombotic or hemorrhagic complications. A bone marrow biopsy then was hypocellular and revealed no fibrosis, dysplastic changes, or increase in blasts. Fluorescence in situ hybridization panel for myelodysplastic syndrome was also negative.", "Question": "What is the patient's Framingham Risk Score?", "LLM Name": "BytedTsinghua-SIA/DAPO-Qwen-32B", "LLM Answer": "0.1", "LLM Explanation": "To calculate the patient's Framingham Risk Score, I followed these steps: 1. Identified the required variables for the Framingham Risk Score: age, gender, smoking status, systolic blood pressure, total cholesterol, HDL cholesterol, and diabetes status. 2. Extracted the data from the patient note: - Age: 50 years - Gender: Male - Smoking status: The note mentions a 3-pack year smoking history, but it doesn't specify current smoking status. Since the note doesn't mention current smoking, I assumed the patient is not a current smoker. - Systolic Blood Pressure: 131 mmHg - Total Cholesterol: Not directly given. We have LDL (107 mg/dL), HDL (43 mg/dL), and triglycerides (98 mg/dL). Using the formula Total Cholesterol = LDL + HDL + (Triglycerides / 5), we get Total Cholesterol = 107 + 43 + (98 / 5) = 107 + 43 + 19.6 = 169.6 mg/dL, which rounds to approximately 170 mg/dL. - HDL Cholesterol: 43 mg/dL - Diabetes: No history of diabetes. 3. Used the Framingham Risk Score points system for men to calculate the total points: - Age 50: 8 points - Systolic BP 131 mmHg: 3 points (since 130-139 mmHg corresponds to 3 points) - Total Cholesterol 170 mg/dL: 2 points (since 160-199 mg/dL corresponds to 2 points) - HDL 43 mg/dL: 0 points (since 35-44 mg/dL corresponds to 0 points) - Smoking: No (0 points) - Diabetes: No (0 points) 4. Summed up the points: 8 (age) + 3 (SBP) + 2 (Total Cholesterol) + 0 (HDL) + 0 (Smoking) + 0 (Diabetes) = 13 points. 5. Looked up the corresponding 10-year risk percentage for 13 points in the Framingham Risk Score table for men. According to the table, 13 points correspond to a 10% risk. Therefore, the patient's Framingham Risk Score corresponds to a 10-year risk of approximately 10% for developing coronary heart disease.", "LLM Thinking": "Okay, so I need to figure out the patient's Framingham Risk Score based on the provided note. Let me start by recalling what the Fram ingham Risk Score is. From what I remember, it's a tool used to estimate the 10-year risk of developing coronary heart disease (CH D) in asymptomatic adults. The score uses various risk factors like age, gender, blood pressure, cholesterol levels, etc. First, I need to check which variables are included in the Framingham Risk Score. Let me try to remember the components. The original Framingham score includes age, smoking status, systolic blood pressure , total cholesterol, HDL cholesterol, and whether the person has diabetes. Also, for men and women, the calculations might differ because they have different baseline risks. Wait, but the patient here is a 50-year-old male. Looking at the patient's data, let me go through each required component step by step. Starting with age: The patient is 50 years old. Since the Framingham score is for 10-year risk, we'll use his current age. So age is 50. Gender: Male, which is important because the risk equations differ. Next, smoking status: The patient has a 3-pack year smoking history. Wait, but the Framingham score requires current smoking status. The note says he has a 3-pack year history, but does it say he's currently smoking? Let me check again. The note mentions his medical history includes a 3-pack year smoking history, but under the review of systems, there's no mention of active smoking. However, the problem is that the Framingham score requires whether the patient is currently a smoker. If he quit, that affects the score. Since the note doesn't explicitly state he is a current smoker, maybe he 's not. But wait, the history is 3-pack years, which is past. So perhaps he quit. But I need to confirm. The note says \"3-pack year smoking history\"\u2014pack years usually refer to cumulative, so he might have quit. So current smoking status is no? But maybe I should check if the Framingham score considers past vs. current . The standard Framingham risk calculator typically uses current smoking status. Since the note doesn't mention current smoking, I might have to assume he 's not a current smoker. But this is a critical point. Alternatively, maybe the 3-pack year is considered as past. Let me see. The problem is that the Framingham score requires knowing if the patient is a current smoker. Since the note doesn't specify, perhaps we can infer from the 3 -pack year that he is not a current smoker, but this might be an assumption. Alternatively, maybe the 3-pack years is current. Wait, 3 pack years would be 3 years of smoking a pack a day. But the note says \"3-pack year smoking history\"\u2014so that's in the past. Therefore, he is not a current smoker. So smoking status is no. Next, systolic blood pressure: His BP on presentation was 131/83. The Framingham score uses the average of two BP readings if possible, but here we only have one. Let me check if the note mentions any other BP. The initial BP is 131/83. The Framingham score requires systolic BP. So 131 mmHg. Let me note that. Cholesterol levels: The Framingham score uses total cholesterol and HDL. However, the note provides LDL, HDL, and trig lycerides. Wait, but total cholesterol is not directly given. The problem is that to compute the Framingham score, we need total cholesterol and HDL. The given data has LDL 107 mg/dL, HDL 43, trig 98. To get total cholesterol, we can use the formula: Total Cholesterol = LDL + HDL + (Triglycerides / 5). So let's calculate that. LDL is 107, HDL 43, trig 98. So total cholesterol would be 107 + 43 + (98/5) = 150 + 19.6 = 169.6 mg/dL approximately. Let me confirm the formula. Yes, the standard method to estimate total cholesterol when LDL is known is to add LDL, HDL, and triglycerides divided by 5. So that gives total cholesterol of about 170 mg/dL (rounded up). HDL cholesterol: 43 mg/dL. Diabetes: The note says he has no history of diabetes, so that's a no. Now, putting all these into the Framingham equations. Since the patient is male, we'll use the male equation. The Framingham risk score for men is calculated using the following points: Age: 50 years Smoking: No Systolic BP: 131 mmHg (whether on treatment or not? The Framingham score uses untreated BP. Here, the BP is 131/83, which is in the hypertensive range but not extremely high. However, the Framingham score uses the actual measured BP, so I think we can proceed with 131. Total Cholesterol: approx 170 mg/dL HDL: 43 mg/dL Diabetes: No The Framingham points are assigned based on these variables. Let me recall the points for each category. Alternatively, maybe it's easier to use the standard Framingham equation. The Framingham risk score for men is calculated using a logistic regression model. The formula is: logit(p) = b0 + b1*age + b2*SBP + b3*log(total cholesterol) + b4*log(HDL) + b5*smoking + b6*diabetes Wait, perhaps I should refer to the points table. Alternatively, maybe I can look up the points for each variable. Alternatively, perhaps it's better to use the standard Framingham points table for men. Let me try to recall. Alternatively, perhaps the points are assigned as follows: For age: 50 years: Looking at the Framingham points tables, for men: Age points: Age 30-34: 0 points, 35-39: 2, 40-44: 4, 45-49: 6, 50-54: 8, 55-59: 10, etc. Wait, but the patient is 50, so age 50 would be in the 50-54 group. So age points: 8 points. Smoking status: non-smoker (0 points), since we assumed no. Systolic BP: 131 mmHg. The systolic BP points depend on whether the patient is on treatment. The Framingham score uses untreated BP. So if the patient is not on antihypertensive therapy, the BP is considered as is. If he is on treatment, it's still recorded, but the points are based on the treated BP. The note doesn't mention any antihypertensive medications, so we can assume untreated BP. For systolic BP, the points are as follows: For men: If SBP <120: 0 points 120-129: 2 points 130-139: 3 points 140-159: 4 points \u2265160: 5 points So 131 is between 130-139, so 3 points. Total Cholesterol: Total Cholesterol (mg/dL): <160: 0 points 160-199: 2 points 200-239: 3 points \u2265240: 4 points Our calculated total cholesterol is ~170, which falls into 160-199, so 2 points. HDL cholesterol: HDL (mg/dL): <35: 1 point 35-44: 0 points 45-49: -1 point >=50: -2 points Wait, the points for HDL in the Framingham are: For men: HDL <35: +1 point 35-44: 0 45-49: -1 >=50: -2 But in our case, HDL is 43 mg/dL, which is 35-44, so 0 points. Smoking: non-smoker, so 0. Diabetes: no, so 0. Putting all together: Age: 8 SBP: 3 Total Cholesterol: 2 HDL: 0 Smoking: 0 Diabetes: 0 Total points: 8+3+2+0+0+0=13. Now, according to the Framingham risk score, each combination of points corresponds to a certain risk. The risk is calculated using the logistic regression equation. Alternatively, the points can be converted to a risk percentage using a table. However, I might need to use the exact formula. Let me check. The Framingham risk score for men uses the following equation (from the original Framingham equation): The formula is: 10-year risk = 1 / (1 + e^-(b0 + b1*age + b2*SBP + b3*log(total cholesterol) + b4*log(HDL) + b5*smoking + b6*diabetes)) But the coefficients (b0 to b6) are specific to the Framingham study. Alternatively, perhaps it's easier to use the points to estimate the risk. Alternatively, the points are summed up, and the total points correspond to a risk percentage using a table. Let me check the standard Framingham risk tables for men. Looking up the Framingham risk tables for men, the points system assigns each variable a certain number of points, and the total points are then looked up in a table to find the corresponding 10-year risk. For example, a total of 0 points corresponds to a 1% risk, 1 point to 2%, 2 points to 3%, ..., up to 12 points corresponding to 10% risk. Wait, but I might be misremembering. Alternatively, perhaps the points go higher. Let me see. Alternatively, here's a standard Framingham points table for men (approximate): Total Points: 0-3 \u2192 <1 % risk 4 \u2192 1% 5 \u2192 2% 6 \u2192 3% 7 \u2192 4% 8 \u2192 5% 9 \u2192 6% 10 \u2192 7% 11 \u2192 8% 12 \u2192 9% 13 \u2192 10% Wait, but this seems inconsistent. Alternatively, another source might show different ranges. Alternatively, perhaps the total points are converted into a risk percentage using a table where 13 points would correspond to a 10% risk. However, I need to verify this. Alternatively, the Framingham Risk Function for Men: The original Framingham equation uses the following coefficients (from the Framingham Heart Study): logit(p) = -6.0263 + (0.0537 * age) + (0.0220 * SBP) + (0.0192 * log(total cholesterol)) + (-0.0316 * log(HDL)) + (0.0185 * smoking) + (0.0163 * diabetes) Wait, but the coefficients here may vary. Alternatively, perhaps the points system is more straightforward. Let me check the actual points for each variable. According to the Framingham Risk Calculator, the points for each variable are: For age: 50 years: 8 points SBP: 131 \u2192 3 points Total Cholesterol: 170 \u2192 2 points HDL: 43 \u2192 0 points Smoking: No \u2192 0 Diabetes: No \u2192 0 Total points: 8+3+2=13. Looking at the Framingham points table for men, the summary: Total Points Risk % 0-3 \u2192 <1% 4 \u2192 1% 5 \u2192 2% 6 \u2192 3% 7 \u2192 4% 8 \u2192 5% 9 \u2192 6% 10 \u2192 7% 11 \u2192 8% 12 \u2192 9% 13 \u2192 10%", "Ground Truth Answer": "0", "Ground Truth Explanation": "The patient's gender is Male.\nFor males, the formula for computing the framingham risk score is 52.00961 * ln(age) + 20.014077 * ln(total_cholestrol) + -0.905964 * ln(hdl_cholestrol) + 1.305784 * ln(sys_bp) + 0.241549 * bp_medicine + 12.096316 * smoker + -4.605038 * ln(age) * ln(total_cholestrol) + -2.84367 * ln(age_smoke) * smoker + -2.93323 * ln(age) * ln(age) -  172.300168, where 'bp_medicine' is a binary variable for whether a patient's blood pressure is being treated with medicine, total cholestrol and hdl cholestrol are in mg/dL, and 'smoker' is whether the patient is a smoker or not.\nFrom this, we use the risk score to get likelihood for a patient getting myocardial infraction (MI) or dying in the next 10 years: 1 - 0.9402^exp(risk_score), where risk_score is the value from the formula above.\nThe patient is 50 years old. The patient is a smoker, making the smoking variable equal to 1.\nThe patient's systolic blood pressure is 131.0 mm Hg.\nThe patient has been specified to not take medication for treating their blood pressure, making the bp_medicine variable equal to 0.\nThe concentration of total cholestrol is 107.0 mg/dL. We need to convert the concentration to mmol/L. Let's first convert the mass of total cholestrol from mg to mmol. The mass of total cholestrol is 107.0 mg. To convert 107.0 mg of total cholestrol to g, multiply by the conversion factor 0.001, giving us 107.0 mg total cholestrol * 0.001 g/mg = 0.107 g total cholestrol. To convert from grams of total cholestrol to moles, divide by the molar mass 386.65 g/mol, which will give 0.107 g/(386.65 g total cholestrol/mol) = 0.000277 mol total cholestrol. To convert 0.000277 mol of total cholestrol to mmol, multiply by the conversion factor 1000.0, giving us 0.000277 mol total cholestrol * 1000.0 mmol/mol = 0.277 mmol total cholestrol. The current volume unit is dL and the target volume unit is L. The conversion factor is 0.1 L for every unit of dL. Our next step will be to divide the mass by the volume conversion factor of 0.1 to get the final concentration in terms of mmol/L. This will result to 0.277 mmol total cholestrol/0.1 L = 2.77 mmol total cholestrol/L. The concentration value of 107.0 mg total cholestrol/dL converts to 2.77 mmol total cholestrol/L. \nThe concentration of hdl cholestrol is 43.0 mg/dL. We need to convert the concentration to mmol/L. Let's first convert the mass of hdl cholestrol from mg to mmol. The mass of hdl cholestrol is 43.0 mg. To convert 43.0 mg of hdl cholestrol to g, multiply by the conversion factor 0.001, giving us 43.0 mg hdl cholestrol * 0.001 g/mg = 0.043 g hdl cholestrol. To convert from grams of hdl cholestrol to moles, divide by the molar mass 386.65 g/mol, which will give 0.043 g/(386.65 g hdl cholestrol/mol) = 0.000111 mol hdl cholestrol. To convert 0.000111 mol of hdl cholestrol to mmol, multiply by the conversion factor 1000.0, giving us 0.000111 mol hdl cholestrol * 1000.0 mmol/mol = 0.111 mmol hdl cholestrol. The current volume unit is dL and the target volume unit is L. The conversion factor is 0.1 L for every unit of dL. Our next step will be to divide the mass by the volume conversion factor of 0.1 to get the final concentration in terms of mmol/L. This will result to 0.111 mmol hdl cholestrol/0.1 L = 1.11 mmol hdl cholestrol/L. The concentration value of 43.0 mg hdl cholestrol/dL converts to 1.11 mmol hdl cholestrol/L. \nPlugging in these values will give us the risk score:  52.00961 * ln(50) + 20.014077 * ln(2.77) + -0.905964 * ln(1.11) + 1.305784 * ln(131.0) + 0.241549 * 0  + 12.096316 * 1 + -4.605038 * ln(50) * ln(2.77) + -2.84367 * ln(50) * 1 + -2.93323 * ln(50) * ln(50) -  172.300168 = -4.4.\nPlugging this into the MI risk equation gives us 1 - 0.9402^exp(-4.4) = 0.0 %.\nThe patient's percentage of getting MI or dying is 0.0 %.", "Result": "Incorrect", "Thought Type": "ensembled_thought_without_answer", "Transferred Thoughts": "Okay, so I need to figure out the patient's Framingham Risk Score based on the provided note. Let me start by recalling what the Fram ingham Risk Score is. From what I remember, it's a tool used to estimate the 10-year risk of developing coronary heart disease (CH D) in asymptomatic adults. The score uses various risk factors like age, gender, blood pressure, cholesterol levels, etc.\n\nFirst, I need to check which variables are included in the Framingham Risk Score. Let me try to remember the components. The original Framingham score includes age, smoking status, systolic blood pressure , total cholesterol, HDL cholesterol, and whether the person has diabetes. Also, for men and women, the calculations might differ because they have different baseline risks. Wait, but the patient here is a 50-year-old male. Looking at the patient's data, let me go through each required component step by step.\n\nStarting with age: The patient is 50 years old. Since the Framingham score is for 10-year risk, we'll use his current age. So age is 50. Gender: Male, which is important because the risk equations differ. Next, smoking status: The patient has a 3-pack year smoking history. Wait, but the Framingham score requires current smoking status. The note says he has a 3-pack year history, but does it say he's currently smoking? Let me check again. The note mentions his medical history includes a 3-pack year smoking history, but under the review of systems, there's no mention of active smoking. However, the problem is that the Framingham score requires whether the patient is currently a smoker. If he quit, that affects the score. Since the note doesn't explicitly state he is a current smoker, maybe he 's not. But wait, the history is 3-pack years, which is past. So perhaps he quit. But I need to confirm. The note says \"3-pack year smoking history\"\u2014pack years usually refer to cumulative, so he might have quit. So current smoking status is no? But maybe I should check if the Framingham score considers past vs. current . The standard Framingham risk calculator typically uses current smoking status. Since the note doesn't mention current smoking, I might have to assume he 's not a current smoker. But this is a critical point. Alternatively, maybe the 3-pack year is considered as past. Let me see. The problem is that the Framingham score requires knowing if the patient is a current smoker. Since the note doesn't specify, perhaps we can infer from the 3 -pack year that he is not a current smoker, but this might be an assumption. Alternatively, maybe the 3-pack years is current. Wait, 3 pack years would be 3 years of smoking a pack a day. But the note says \"3-pack year smoking history\"\u2014so that's in the past. Therefore, he is not a current smoker. So smoking status is no.\n\nNext, systolic blood pressure: His BP on presentation was 131/83. The Framingham score uses the average of two BP readings if possible, but here we only have one. Let me check if the note mentions any other BP. The initial BP is 131/83. The Framingham score requires systolic BP. So 131 mmHg. Let me note that.\n\nCholesterol levels: The Framingham score uses total cholesterol and HDL. However, the note provides LDL, HDL, and trig lycerides. Wait, but total cholesterol is not directly given. The problem is that to compute the Framingham score, we need total cholesterol and HDL. The given data has LDL 107 mg/dL, HDL 43, trig 98. To get total cholesterol, we can use the formula: Total Cholesterol = LDL + HDL + (Triglycerides / 5). So let's calculate that.\n\nLDL is 107, HDL 43, trig 98. So total cholesterol would be 107 + 43 + (98/5) = 150 + 19.6 = 169.6 mg/dL approximately. Let me confirm the formula. Yes, the standard method to estimate total cholesterol when LDL is known is to add LDL, HDL, and triglycerides divided by 5. So that gives total cholesterol of about 170 mg/dL (rounded up).\n\nHDL cholesterol: 43 mg/dL. Diabetes: The note says he has no history of diabetes, so that's a no.\n\nNow, putting all these into the Framingham equations. Since the patient is male, we'll use the male equation. The Framingham risk score for men is calculated using the following points:\n\nAge: 50 years  \nSmoking: No  \nSystolic BP: 131 mmHg (whether on treatment or not? The Framingham score uses untreated BP. Here, the BP is 131/83, which is in the hypertensive range but not extremely high. However, the Framingham score uses the actual measured BP, so I think we can proceed with 131.  \nTotal Cholesterol: approx 170 mg/dL  \nHDL: 43 mg/dL  \nDiabetes: No  \n\nThe Framingham points are assigned based on these variables. Let me recall the points for each category. Alternatively, maybe it's easier to use the standard Framingham equation. The Framingham risk score for men is calculated using a logistic regression model. The formula is:\n\nlogit(p) = b0 + b1*age + b2*SBP + b3*log(total cholesterol) + b4*log(HDL) + b5*smoking + b6*diabetes\n\nWait, perhaps I should refer to the points table. Alternatively, maybe I can look up the points for each variable. Alternatively, perhaps it's better to use the standard Framingham points table for men. Let me try to recall. Alternatively, perhaps the points are assigned as follows:\n\nFor age:\n\n50 years:\n\nLooking at the Framingham points tables, for men: Age points:  \nAge 30-34: 0 points, 35-39: 2, 40-44: 4, 45-49: 6, 50-54: 8, 55-59: 10, etc. Wait, but the patient is 50, so age 50 would be in the 50-54 group. So age points: 8 points. Smoking status: non-smoker (0 points), since we assumed no. Systolic BP: 131 mmHg. The systolic BP points depend on whether the patient is on treatment. The Framingham score uses untreated BP. So if the patient is not on antihypertensive therapy, the BP is considered as is. If he is on treatment, it's still recorded, but the points are based on the treated BP. The note doesn't mention any antihypertensive medications, so we can assume untreated BP. For systolic BP, the points are as follows:\n\nFor men:  \nIf SBP <120: 0 points  \n120-129: 2 points  \n130-139: 3 points  \n140-159: 4 points  \n\u2265160: 5 points  \n\nSo 131 is between 130-139, so 3 points. Total Cholesterol:\n\nTotal Cholesterol (mg/dL):  \n<160: 0 points  \n160-199: 2 points  \n200-239: 3 points  \n\u2265240: 4 points  \n\nOur calculated total cholesterol is ~170, which falls into 160-199, so 2 points. HDL cholesterol:\n\nHDL (mg/dL):  \n<35: 1 point  \n35-44: 0 points  \n45-49: -1 point  \n>=50: -2 points  \n\nWait, the points for HDL in the Framingham are: For men:  \nHDL <35: +1 point  \n35-44: 0  \n45-49: -1  \n>=50: -2  \n\nBut in our case, HDL is 43 mg/dL, which is 35-44, so 0 points. Smoking: non-smoker, so 0. Diabetes: no, so 0.\n\nPutting all together:\n\nAge: 8  \nSBP: 3  \nTotal Cholesterol: 2  \nHDL: 0  \nSmoking: 0  \nDiabetes: 0  \n\nTotal points: 8+3+2+0+0+0=13.\n\nNow, according to the Framingham risk score, each combination of points corresponds to a certain risk. The risk is calculated using the logistic regression equation. Alternatively, the points can be converted to a risk percentage using a table. However, I might need to use the exact formula. Let me check. The Framingham risk score for men uses the following equation (from the original Framingham equation):\n\nThe formula is:\n\n10-year risk = 1 / (1 + e^-(b0 + b1*age + b2*SBP + b3*log(total cholesterol) + b4*log(HDL) + b5*smoking + b6*diabetes))\n\nBut the coefficients (b0 to b6) are specific to the Framingham study. Alternatively, perhaps it's easier to use the points to estimate the risk. Alternatively, the points are summed up, and the total points correspond to a risk percentage using a table. Let me check the standard Framingham risk tables for men.\n\nLooking up the Framingham risk tables for men, the points system assigns each variable a certain number of points, and the total points are then looked up in a table to find the corresponding 10-year risk. For example, a total of 0 points corresponds to a 1% risk, 1 point to 2%, 2 points to 3%, ..., up to 12 points corresponding to 10% risk. Wait, but I might be misremembering. Alternatively, perhaps the points go higher. Let me see.\n\nAlternatively, here's a standard Framingham points table for men (approximate):\n\nTotal Points: 0-3 \u2192 <1 % risk  \n4 \u2192 1%  \n5 \u2192 2%  \n6 \u2192 3%  \n7 \u2192 4%  \n8 \u2192 5%  \n9 \u2192 6%  \n10 \u2192 7%  \n11 \u2192 8%  \n12 \u2192 9%  \n13 \u2192 10%\n\nWait, but this seems inconsistent. Alternatively, another source might show different ranges. Alternatively, perhaps the total points are converted into a risk percentage using a table where 13 points would correspond to a 10% risk. However, I need to verify this.\n\nAlternatively, the Framingham Risk Function for Men:\n\nThe original Framingham equation uses the following coefficients (from the Framingham Heart Study):\n\nlogit(p) = -6.0263 + (0.0537 * age) + (0.0220 * SBP) + (0.0192 * log(total cholesterol)) + (-0.0316 * log(HDL)) + (0.0185 * smoking) + (0.0163 * diabetes)\n\nWait, but the coefficients here may vary. Alternatively, perhaps the points system is more straightforward. Let me check the actual points for each variable. According to the Framingham Risk Calculator, the points for each variable are: For age:\n\n50 years: 8 points  \nSBP: 131 \u2192 3 points  \nTotal Cholesterol: 170 \u2192 2 points  \nHDL: 43 \u2192 0 points  \nSmoking: No \u2192 0  \nDiabetes: No \u2192 0  \n\nTotal points: 8+3+2=13.\n\nLooking at the Framingham points table for men, the summary:\n\nTotal Points  Risk %  \n0-3         \u2192 <1%  \n4           \u2192 1%  \n5           \u2192 2%  \n6           \u2192 3%  \n7           \u2192 4%  \n8           \u2192 5%  \n9           \u2192 6%  \n10          \u2192 7%  \n11          \u2192 8%  \n12          \u2192 9%  \n13          \u2192 10%"}
{"Row Number": 875, "Calculator Name": "APACHE II Score", "Calculator ID": "28", "Category": "risk", "Note ID": "8", "Patient Note": "A 60-year-old male with a history of liver failure and immunocompromise presents to the emergency department with acute symptoms of lethargy and decreased appetite. Physical examination reveals tachycardia to 95 beats per minute, respiratory rate of 19 breaths per minute, blood pressure registering at 135/75 mm Hg and a baseline temperature of 37.2\u00b0C. Neurological assessment demonstrates mild confusion, corresponding to a Glasgow Coma Score of 14. Blood tests reveal elevated creatinine levels at 3.8 mg/dL. Metabolic panel showed sodium at 138 and potassium at 4.5 mEq/L. The white blood cell count was 12,000 per \u00b5L, triggering concern for a possible infection. Hematocrit was just within normal range at 43 %. The patient had an arterial blood gas pH of 7.32 and a A-a-gradient of 364, with a supplementary FiO\u2082 of 55 %. This patient's acute renal failure symptomatology, alongside the history of severe organ failure and immunocompromised, mandate rigorous monitoring and urgent medical intervention.", "Question": "What is the patient's APACHE II score?", "LLM Name": "BytedTsinghua-SIA/DAPO-Qwen-32B", "LLM Answer": "11", "LLM Explanation": "To calculate the APACHE II score for the patient, I followed these steps:\\n\\n1. Age: The patient is 60 years old, which falls into the \u226560 category, scoring 2 points.\\n2. Systolic Blood Pressure (SBP): The SBP is 135 mm Hg, which falls within the 130\u2013200 range, scoring 0 points.\\n3. Heart Rate (HR): The HR is 95 bpm, which falls within the 70\u2013109 range, scoring 0 points.\\n4. Temperature: The temperature is 37.2 \u00b0C, which falls within the 36.1\u201338.0 range, scoring 0 points.\\n5. Respiratory Rate (RR): The RR is 19 breaths per minute, which falls within the 16\u201320 range, scoring 0 points.\\n6. Respiratory (PaO2/FiO2): Given the high A\u2013a gradient of 364 mm Hg and FiO2 of 55%, I estimated a very low PaO2, leading to a PaO2/FiO2 ratio below 200, giving a score of 3.\\n7. Mean Arterial Pressure (MAP): The MAP is 95 mm Hg, which is \u226580, scoring 0 points.\\n8. Serum Creatinine: The serum creatinine is 3.8 mg/dL, which is \u22653.5, scoring 3 points.\\n9. Bilirubin: Not provided, but assuming a high bilirubin level due to liver failure, I assigned a score of 2.\\n10. pH: The pH is 7.32, which falls within the 7.3\u20137.4 range, scoring 0 points.\\n11. PaCO2: Assuming a PaCO2 of around 45 mm Hg based on the slightly low pH, it falls into the 45\u201354 range, scoring 1 point.\\n12. Glucose: Not provided, so assuming a normal glucose level, scoring 0 points.\\n\\nAdding up all the scores: 2 (Age) + 0 (SBP) + 0 (HR) + 0 (Temperature) + 0 (RR) + 3 (Respiratory) + 0 (MAP) + 3 (Serum Creatinine) + 2 (Bilirubin) + 0 (pH) + 1 (PaCO2) + 0 (Glucose) = 11.", "LLM Thinking": "Okay, I need to calculate the APACHE II score for this patient. Let me start by recalling what APACHE II is. It's a scoring system used to predict mortality in critically ill patients, based on various parameters like age, acuity of illness, physiological variables, etc. The total score ranges from 0 to 71, with higher scores indicating worse prognosis. The components include age, 12 physiological parameters measured within the first 24 hours of ICU admission, and the worst value for each parameter over the first two days. First, let's list all the necessary data from the patient note. The patient is a 60-year-old male. His current vital signs and lab results are provided. But wait, APACHE II requires data from the first 24 hours in the ICU, but since this is an emergency department presentation, maybe we'll use the initial values here. Let me go through each component of the APACHE II score step by step. 1. Age: The patient is 60. The age category in APACHE II is: \u226414 (1 point), 15\u201344 (0), 45\u201359 (1), \u226560 (2). 2. Systolic Blood Pressure (SBP): The blood pressure is 135/75. APACHE II uses SBP. The SBP categories are: <90 (4), 90\u201399 (3), 100\u2013109 (2), 110\u2013129 (1), 130\u2013200 (0), and >200 (3). 3. Heart Rate (HR): 95 bpm. The HR categories are: <50 (2), 50\u201369 (1), 70\u2013109 (0), 110\u2013129 (1), 130\u2013149 (2), \u2265150 (3). 4. Temperature: 37.2 \u00b0C. APACHE II uses temperature in Fahrenheit. Wait, no, actually the temperature categories in APACHE II are in Celsius. For temperature, the formula is (T \u2013 36)/0.15. But actually, the APACHE II temperature scoring is based on the temperature in Celsius: <35.0 (3), 35.0\u201336.0 (2), 36.1\u201338.0 (0), 38.1\u201339.0 (1), >39.0 (2). 5. Respiratory Rate (RR): 19. The RR categories are: <8 (3), 8\u201311 (2), 12\u201315 (1), 16\u201320 (0), 21\u201329 (1), \u226530 (2). 6. PaO2: Wait, the note mentions an arterial blood gas pH of 7.32 and an A\u2013a gradient of 364 with FiO2 of 55%. But APACHE II uses PaO2. However, the A\u2013a gradient might not directly give PaO2. The APACHE II respiratory component is based on PaO2 and FiO2. The formula for the respiratory score is (PaO2/FiO2) \u00d7 0.1. The APACHE II respiratory score is calculated as follows: If PaO2/FiO2 <200 \u2192 score 3 200\u2013300 \u2192 2 301\u2013400 \u2192 1 >400 \u2192 0 But if PaO2/FiO2 is not available, but we have A\u2013a gradient and FiO2, perhaps we can estimate PaO2. The A\u2013a gradient formula is: A\u2013a gradient = (FiO2 \u00d7 (Patm \u2013 H2O)) \u2013 PaCO2 \u2013 PaO2. Assuming Patm is 760 mm Hg, H2O is 47 mm Hg, FiO2 is 0.55, then FiO2 \u00d7 (Patm \u2013 H2O) = 0.55 \u00d7 713. Then you subtract PaCO2 and PaO2 to get the gradient. You can rearrange to solve for PaO2 if you know the gradient and PaCO2. 7. Mean Arterial Pressure (MAP): APACHE II uses MAP. MAP is calculated as (systolic + 2\u00d7diastolic)/3. The MAP categories in APACHE II are: <60 (3), 60\u201369 (2), 70\u201379 (1), \u226580 (0). 8. Serum Creatinine: Elevated to 3.8 mg/dL. APACHE II uses serum creatinine (Cr). The categories are: <1.0 (0), 1.0\u20131.9 (1), 2.0\u20133.4 (2), \u22653.5 (3). 9. Bilirubin: Not mentioned. The patient has a history of liver failure, but the note doesn't specify bilirubin levels. APACHE II requires bilirubin. Since it's not provided, we might have to note it as missing. 10. pH: The pH is 7.32. The pH score in APACHE II is based on the pH value: pH <7.3 (2), 7.3\u20137.4 (0), >7.4 (1). 11. PaCO2: Using the normal equation: pH = 7.4 \u2013 0.02 \u00d7 PaCO2. The PaCO2 categories in APACHE II are: <30 (3), 30\u201344 (0), 45\u201354 (1), \u226555 (2). 12. Glucose: Not mentioned. APACHE II includes glucose in the set of physiological parameters. Serum Sodium: 138. The sodium categories are: <110, 110\u2013120, 121\u2013131, 132\u2013144, 145\u2013155, >155. Serum Potassium: 4.5. The potassium categories are: <2.5, 2.5\u20133.4, 3.5\u20135.4, 5.5\u20136.9, \u22657.0. Hematocrit: 43%. The hematocrit categories are: <20, 20\u201329.9, 30\u201345, 46\u201350, >50.", "Ground Truth Answer": "36", "Ground Truth Explanation": "The patient's current APACHE II score is 0 points.\nThe patient is 60.0 years old. The patient is reported to have an organ failure of immunocompromise with a surgery type being classified as Nonoperative. Because the patient's age is between 55 and 64, 3 points are added to the total, making the current total, 0 + 3 = 3.\nThe patient's FiO2 percentage is 55.0 %. Because the patent's FiO2 percentrage is greater than 50%, we need to examine the A-a-gradient to compute the APACHE II score. The patient's A-a-gradient is 364. Because the patient's A-a gradient is between 350 and 500, we add 3 points to the total, making the current total 6.\nThe patient's temperature is 37.2 degrees fahrenheit. To convert to degrees celsius, apply the formula 5/9 * [temperature (degrees fahrenheit) - 32]. This means that the patient's temperature is 5/9 * 5.200000000000003 = 2.889 degrees celsius. \nBecause the patient's temperature is below 30 degrees Celsius, 4 points are added to the score, making the current total, 6 + 4 = 10.\nThe mean average pressure is computed by the formula 2/3 * (diastolic blood pressure) + 1/3 * (systolic blood pressure). Plugging in the values, we get 2/3 * 75.0 mm Hg + 1/3 * 135.0 mm Hg = 95.0 mm Hg.\nHence, the patient's mean arterial pressure is 95.0 mm Hg.\nBecause the patient's Mean Arterial Pressure is between 70 and 109 mmHg, 0 points are added to the patient's score, keeping the total at 10.\nBecause the patient's heart rate is between 70 and 109 beats per minute, 0 points are added to the patient's score, keeping the total at 10.\nBecause the patient's respiratory rate is between 12 and 24 breaths per minute, 0 points are added to the patient's score, keeping the total at 10.\nBecause the patient's sodium level is between 130 and 149 mmol/L, 0 points are added to the patient's score, keeping the total at 10. Because the patient's potassium level is between 3.5 and 5.4 mmol/L, 0 points are added to the patient's score, keeping the total at 10. Because the patient has acute renal failure and a creatinine level above 3.5, 8 points are added to the score, making the current total 10 + 8 = 18.\nBecause the patient's hemocratit is between 30% and 45%, 0 points are added to the patient's score, keeping the total at 18. Because the patient's white blood cell count is above 40 x10^9/L, 4 points are added to the score, making the current total 18 + 4 = 22.\nThe patient's Glasgow Coma Score is 14.0, and so we add 14.0 points to the total making the current total 14.0 + 22 = 36.0. Hence, the patient's APACHE II score is 36.0.", "Result": "Incorrect", "Thought Type": "ensembled_thought_without_answer", "Transferred Thoughts": "Okay, I need to calculate the APACHE II score for this patient.  \nLet me start by recalling what APACHE II is.  \nIt's a scoring system used to predict mortality in critically ill patients, based on various parameters like age, acuity of illness, physiological variables, etc.  \nThe total score ranges from 0 to 71, with higher scores indicating worse prognosis.  \nThe components include age, 12 physiological parameters measured within the first 24 hours of ICU admission, and the worst value for each parameter over the first two days.  \n\nFirst, let's list all the necessary data from the patient note.  \nThe patient is a 60-year-old male.  \nHis current vital signs and lab results are provided.  \nBut wait, APACHE II requires data from the first 24 hours in the ICU, but since this is an emergency department presentation, maybe we'll use the initial values here.  \n\nLet me go through each component of the APACHE II score step by step.  \n\n1. Age: The patient is 60.  \n   The age category in APACHE II is: \u226414 (1 point), 15\u201344 (0), 45\u201359 (1), \u226560 (2).  \n\n2. Systolic Blood Pressure (SBP): The blood pressure is 135/75.  \n   APACHE II uses SBP.  \n   The SBP categories are: <90 (4), 90\u201399 (3), 100\u2013109 (2), 110\u2013129 (1), 130\u2013200 (0), and >200 (3).  \n\n3. Heart Rate (HR): 95 bpm.  \n   The HR categories are: <50 (2), 50\u201369 (1), 70\u2013109 (0), 110\u2013129 (1), 130\u2013149 (2), \u2265150 (3).  \n\n4. Temperature: 37.2 \u00b0C.  \n   APACHE II uses temperature in Fahrenheit.  \n   Wait, no, actually the temperature categories in APACHE II are in Celsius.  \n   For temperature, the formula is (T \u2013 36)/0.15.  \n   But actually, the APACHE II temperature scoring is based on the temperature in Celsius: <35.0 (3), 35.0\u201336.0 (2), 36.1\u201338.0 (0), 38.1\u201339.0 (1), >39.0 (2).  \n\n5. Respiratory Rate (RR): 19.  \n   The RR categories are: <8 (3), 8\u201311 (2), 12\u201315 (1), 16\u201320 (0), 21\u201329 (1), \u226530 (2).  \n\n6. PaO2:  \n   Wait, the note mentions an arterial blood gas pH of 7.32 and an A\u2013a gradient of 364 with FiO2 of 55%.  \n   But APACHE II uses PaO2.  \n   However, the A\u2013a gradient might not directly give PaO2.  \n   The APACHE II respiratory component is based on PaO2 and FiO2.  \n   The formula for the respiratory score is (PaO2/FiO2) \u00d7 0.1.  \n   The APACHE II respiratory score is calculated as follows:  \n     If PaO2/FiO2 <200 \u2192 score 3  \n     200\u2013300 \u2192 2  \n     301\u2013400 \u2192 1  \n     >400 \u2192 0  \n   But if PaO2/FiO2 is not available, but we have A\u2013a gradient and FiO2, perhaps we can estimate PaO2.  \n   The A\u2013a gradient formula is: A\u2013a gradient = (FiO2 \u00d7 (Patm \u2013 H2O)) \u2013 PaCO2 \u2013 PaO2.  \n   Assuming Patm is 760 mm Hg, H2O is 47 mm Hg, FiO2 is 0.55, then FiO2 \u00d7 (Patm \u2013 H2O) = 0.55 \u00d7 713.  \n   Then you subtract PaCO2 and PaO2 to get the gradient.  \n   You can rearrange to solve for PaO2 if you know the gradient and PaCO2.  \n\n7. Mean Arterial Pressure (MAP):  \n   APACHE II uses MAP.  \n   MAP is calculated as (systolic + 2\u00d7diastolic)/3.  \n   The MAP categories in APACHE II are: <60 (3), 60\u201369 (2), 70\u201379 (1), \u226580 (0).  \n\n8. Serum Creatinine: Elevated to 3.8 mg/dL.  \n   APACHE II uses serum creatinine (Cr).  \n   The categories are: <1.0 (0), 1.0\u20131.9 (1), 2.0\u20133.4 (2), \u22653.5 (3).  \n\n9. Bilirubin: Not mentioned.  \n   The patient has a history of liver failure, but the note doesn't specify bilirubin levels.  \n   APACHE II requires bilirubin.  \n   Since it's not provided, we might have to note it as missing.  \n\n10. pH: The pH is 7.32.  \n    The pH score in APACHE II is based on the pH value:  \n      pH <7.3 (2), 7.3\u20137.4 (0), >7.4 (1).  \n\n11. PaCO2:  \n    Using the normal equation: pH = 7.4 \u2013 0.02 \u00d7 PaCO2.  \n    The PaCO2 categories in APACHE II are: <30 (3), 30\u201344 (0), 45\u201354 (1), \u226555 (2).  \n\n12. Glucose: Not mentioned.  \n    APACHE II includes glucose in the set of physiological parameters.  \n\nSerum Sodium: 138. The sodium categories are: <110, 110\u2013120, 121\u2013131, 132\u2013144, 145\u2013155, >155.  \nSerum Potassium: 4.5. The potassium categories are: <2.5, 2.5\u20133.4, 3.5\u20135.4, 5.5\u20136.9, \u22657.0.  \nHematocrit: 43%. The hematocrit categories are: <20, 20\u201329.9, 30\u201345, 46\u201350, >50."}
{"Row Number": 981, "Calculator Name": "Target weight", "Calculator ID": "61", "Category": "physical", "Note ID": "14", "Patient Note": "Patient has a height of 77 in and their target BMI is 19.7 kg/m^2.", "Question": "Based on the patient's height and target BMI, what is the patient's target weight in kg?", "LLM Name": "BytedTsinghua-SIA/DAPO-Qwen-32B", "LLM Answer": "75.34", "LLM Explanation": "To find the target weight, we use the formula for BMI: BMI = weight (kg) / (height (m))^2. Rearranging this to solve for weight gives us: weight = BMI * (height)^2. The given height is 77 inches. First, convert the height from inches to meters. Since 1 inch = 0.0254 meters, the height in meters is 77 * 0.0254 = 1.9558 meters. The target BMI is 19.7 kg/m^2. Now, we need to calculate the square of the height: (1.9558)^2 \u2248 3.8250936644 m^2. Next, we plug this into the formula for weight: weight = 19.7 * 3.8250936644. Using a calculator, 19.7 * 3.8250936644 \u2248 75.3443568999 kg. Rounding this to a reasonable precision gives us approximately 75.34 kg.", "LLM Thinking": "Okay, let's see. The problem is to find the target weight of a patient based on their height and target BMI. The given height is 77 inches, and the target BMI is 19.7 kg/m\u00b2. Hmm, right. I remember that BMI is calculated as weight divided by height squared, but the units here need to be consistent. Since the target BMI is in kg/m\u00b2, the height should be converted from inches to meters because the standard BMI formula uses meters. Wait, actually, the formula is BMI = weight (kg) / (height (m))^2. So first, I need to convert the height from inches to meters. Let me recall the conversion factors. There are 12 inches in a foot and 3.28 084 feet in a meter, so 1 inch is 0 .0254 meters. Let me verify that. Yes, 1 inch equals exactly 0. 0254 meters. So to convert 77 inches to meters, multiply by 0. 0254. Let me calculate that. 77 * 0.0254. Let me do this step by step. 70 * 0.0254 is 1.778, and 7 * 0.0254 is 0.1778. Adding those together: 1.778 + 0.1778 = 1.9558 meters. Wait, let me check that again. 77 inches times 0.0254 meters per inch. So 77 * 0.0254. Let me compute 77 * 0.0254. Alternatively, 77 * 2.54 cm, then convert to meters. Wait, maybe breaking it down differently. 1 inch = 2.54 cm, so 77 inches * 2.54 cm/inch = 77 * 2.54 cm. Then convert cm to meters by dividing by 100. Let me compute 77 * 2.54. 70*2.54=177.8, and 7*2.54=17.78. Adding them gives 177.8 + 17.78 = 195.58 cm. Then divide by 100 to get meters: 1.9558 meters. Yes, that\u2019s correct. So the height in meters is approximately 1.9558 m. Now, the BMI formula rearranged to solve for weight is weight = BMI * (height)^2. So plugging in the numbers: weight = 19.7 kg/m\u00b2 * (1.9558 m)^2. First, compute the square of the height. Let me calculate 1.9558 squared. Let\u2019s see. 1.9558 * 1.9558. Let me compute this step by step. 2 squared is 4, so a bit less than that. Let me do 1.9558 squared: (1.9558)^2 = (2 \u2013 0.0442)^2 = 2\u00b2 \u2013 2*2*0.0442 + (0.0442)\u00b2. Wait, maybe it\u2019s easier to just multiply it out: 1.9558 * 1.9558. Let me do this multiplication: First, 1.9 * 1.9 = 3.61 1.9 * 0.0558 \u2248 0.10502 0.05 * 1.9558 = 0.09779 Wait, perhaps this is getting too complicated. Maybe use a calculator approach. Alternatively, approximate the value. Alternatively, maybe it\u2019s better to use a calculator-like step here. Let me proceed step by step. Alternatively, maybe I can use an approximate value for the square. Let me see, 1.9558 is approximately 1.96. The square of 1.96 is 3.8416. But our number is slightly less than 1.96, so the square will be slightly less than 3.8416. For example, if we take 1.9558 = 1.96 \u2013 0.0042, using (a \u2013 b)\u00b2 = a\u00b2 \u2013 2ab + b\u00b2, where a=1.96, b=0.0042: (a \u2013 b)\u00b2 = (1.96)\u00b2 \u2013 2*1.96*0.0042 + (0.0042)\u00b2. So the square is approximately 3.825. So the height squared is approximately 3.825 m\u00b2. Alternatively, maybe my approximation is off. Let me try multiplying 1.9558 * 1.9558 directly: When multiplying two decimals, you can ignore the decimal points initially, multiply the numbers as integers, then count the total number of decimal places in both numbers and place the decimal accordingly. However, since both numbers have multiple decimal places, this might be complex. Alternatively, maybe it\u2019s better to use a calculator method here. Let me proceed step by step.", "Ground Truth Answer": "75.371", "Ground Truth Explanation": "The patient's target bmi is 19.7 kg/m^2. The patient's height is 77 in, which is 77 in * 0.0254 m / in = 1.956 m. From this, the patient's target weight is 19.7 kg/m^2 * 1.956 m * 1.956 m = 75.371 kg. ", "Result": "Correct", "Thought Type": "ensembled_thought_without_answer", "Transferred Thoughts": "Okay, let's see. The problem is to find the target weight of a patient based on their height and target BMI.  \nThe given height is 77 inches, and the target BMI is 19.7 kg/m\u00b2.  \nHmm, right. I remember that BMI is calculated as weight divided by height squared, but the units here need to be consistent.  \nSince the target BMI is in kg/m\u00b2, the height should be converted from inches to meters because the standard BMI formula uses meters.  \nWait, actually, the formula is BMI = weight (kg) / (height (m))^2. So first, I need to convert the height from inches to meters.\n\nLet me recall the conversion factors. There are 12 inches in a foot and 3.28 084 feet in a meter, so 1 inch is 0 .0254 meters.  \nLet me verify that. Yes, 1 inch equals exactly 0. 0254 meters.  \nSo to convert 77 inches to meters, multiply by 0. 0254. Let me calculate that. 77 * 0.0254. Let me do this step by step.  \n70 * 0.0254 is 1.778, and 7 * 0.0254 is 0.1778. Adding those together: 1.778 + 0.1778 = 1.9558 meters.  \nWait, let me check that again. 77 inches times 0.0254 meters per inch. So 77 * 0.0254. Let me compute 77 * 0.0254.  \nAlternatively, 77 * 2.54 cm, then convert to meters. Wait, maybe breaking it down differently. 1 inch = 2.54 cm, so 77 inches * 2.54 cm/inch = 77 * 2.54 cm.  \nThen convert cm to meters by dividing by 100. Let me compute 77 * 2.54. 70*2.54=177.8, and 7*2.54=17.78. Adding them gives 177.8 + 17.78 = 195.58 cm.  \nThen divide by 100 to get meters: 1.9558 meters. Yes, that\u2019s correct.  \nSo the height in meters is approximately 1.9558 m.\n\nNow, the BMI formula rearranged to solve for weight is weight = BMI * (height)^2.  \nSo plugging in the numbers: weight = 19.7 kg/m\u00b2 * (1.9558 m)^2.\n\nFirst, compute the square of the height. Let me calculate 1.9558 squared. Let\u2019s see. 1.9558 * 1.9558. Let me compute this step by step.  \n2 squared is 4, so a bit less than that. Let me do 1.9558 squared:\n\n(1.9558)^2 = (2 \u2013 0.0442)^2 = 2\u00b2 \u2013 2*2*0.0442 + (0.0442)\u00b2.  \nWait, maybe it\u2019s easier to just multiply it out: 1.9558 * 1.9558. Let me do this multiplication:\n\nFirst, 1.9 * 1.9 = 3.61  \n1.9 * 0.0558 \u2248 0.10502  \n0.05 * 1.9558 = 0.09779  \nWait, perhaps this is getting too complicated. Maybe use a calculator approach. Alternatively, approximate the value. Alternatively, maybe it\u2019s better to use a calculator-like step here. Let me proceed step by step.\n\nAlternatively, maybe I can use an approximate value for the square. Let me see, 1.9558 is approximately 1.96. The square of 1.96 is 3.8416. But our number is slightly less than 1.96, so the square will be slightly less than 3.8416.  \nFor example, if we take 1.9558 = 1.96 \u2013 0.0042, using (a \u2013 b)\u00b2 = a\u00b2 \u2013 2ab + b\u00b2, where a=1.96, b=0.0042:\n\n(a \u2013 b)\u00b2 = (1.96)\u00b2 \u2013 2*1.96*0.0042 + (0.0042)\u00b2.  \nSo the square is approximately 3.825. So the height squared is approximately 3.825 m\u00b2.  \nAlternatively, maybe my approximation is off. Let me try multiplying 1.9558 * 1.9558 directly:\n\nWhen multiplying two decimals, you can ignore the decimal points initially, multiply the numbers as integers, then count the total number of decimal places in both numbers and place the decimal accordingly. However, since both numbers have multiple decimal places, this might be complex. Alternatively, maybe it\u2019s better to use a calculator method here. Let me proceed step by step."}
{"Row Number": 32, "Calculator Name": "CKD-EPI Equations for Glomerular Filtration Rate", "Calculator ID": "3", "Category": "lab", "Note ID": "pmc-7983145-1", "Patient Note": "A 38-year-old female was admitted to the emergency ward with altered sensorium and anuria. She had off and on constitutional symptoms of disease such as general malaise, myalgia, polyarthralgia (mainly involved knee, elbow, and ankle joints), anorexia, weight loss, headache, and pyrexia from the last 4 years. She also had a history of recurrent blood-stained nasal discharge, epistaxis, nasal crusting, nasal ulceration, cough, breathlessness, stridor, and wheeze from the last 3 years. She had a history of pedal edema 3 months back. She also complained of diminution of vision with redness of eyes from 3 months. The patient had a history of ulcers on lips and tongue from the past 4 days and decreased frequency of urination from 3 days. There is no history of hematuria, hemoptysis, or cardiovascular manifestations. On examination, her vitals were deranged; she had tachycardia (120/bpm) and hypotension (100/60 mm of Hg). She also had pallor and bilateral pedal edema. There was high suspicion of GPA with acute renal failure or rapidly progressive glomerulonephritis associated with systemic small-vessel vasculitis. Keeping these two main diagnoses in mind, the investigations were ordered accordingly.\nIt is based on a combination of clinical manifestations of systemic disease, positive ANCA serology, and histological evidence of necrotizing vasculitis, necrotizing glomerulonephritis, or granulomatous inflammation of affected organs such as skin, lung, or kidney.\nA trucut biopsy was taken from the right kidney of the patient and detailed analysis was done. On light microscopy, there was focal segmental necrotizing glomerulonephritis involving more than 60% glomeruli associated with extracapillary proliferation with pauci-immune crescent formation. Electron microscopic examination showed fibrinoid deposition in the glomerular basement membrane. In biochemistry, serum sodium (159 mmol/L) and serum potassium levels (17 mmol/L) were deranged. In kidney panel, serum urea (155.8 mg/dL) and serum creatinine levels (8.9 mg/dL) were highly increased suggesting severe form of disease.\nOn performing ANCA serology, her serum showed a predominantly diffuse, granular cytoplasmic ANCA (c-ANCA) staining pattern on indirect immunofluorescence. By direct enzyme-linked immunosorbent assay, there were high titers of ANCA directed against proteinase-3 (PR-3). PR-3 (1:100 with 1+ intensity) was highly raised and confirmed the diagnosis of granulomatosis with polyangiitis associated with c-ANCA positivity.\nThe patient underwent two sessions of hemodialysis with a 2-day interval with packed red cell transfusion. Following that, serum urea and creatinine levels were controlled. Due to high levels of circulating c-ANCA autoantibodies, TPE was planned in addition to the standard therapy. GPA comes under category I, Grade 1A; American Society for Apheresis guidelines 2016.[] TPE sessions were started on the 4thday of admission. A total of seven cycles was performed with 1.3 total plasma volumes exchanged on every alternate day. Fresh frozen plasma (FFP) and normal saline were used as replacement fluids. During the third cycle of TPE after 5 units of FFP transfusion, the patient developed allergic reaction in the form of severe itching all over the body. To treat allergic reaction, oral pheniramine maleate 5 mg and injection hydrocortisone 100 mg intravenous (i.v.) were given, and after 20 min, procedure was restarted and completed successfully. Rest six cycles of TPE was done uneventfully. Simultaneously, standard induction therapy was also started that comprised of combination of cyclophosphamide (500 mg, i.v.) and methylprednisolone 1000 mg, i.v. daily for 3 days followed by oral prednisolone 60 mg daily for at least 4 weeks. Mesna 200 mg slow i.v. over 2 h was also given to prevent cyclophosphamide-induced hemorrhagic cystitis. Regular monitoring of full blood count, serum proteins, renal function, liver function, urine cytology, and clinical symptoms were done. After seven cycles of TPE, the patient was improved clinically as indicated by her renal function tests and ANCA serology and hence TPE was stopped. The patient's recovery was faster due to the timely intervention of TPE along with standard immunosuppression therapy. The total hospital stay of patient was 18 days which was lesser in comparison to the patient who were treated with standard therapy alone. After that, the patient was on maintenance therapy with azathioprine (2 mg/kg/body weight) at least for 12 months and advised for monthly follow-up.", "Question": "Using the 2021 CKD-EPI Creatinine equation, what is the patient's Glomerular Filtration Rate (GFR) in terms of mL/min/1.73 m\u00b2?", "LLM Name": "BytedTsinghua-SIA/DAPO-Qwen-32B", "LLM Answer": "5", "LLM Explanation": "To calculate the patient's GFR using the 2021 CKD-EPI Creatinine equation, I used the following steps:\\n1. Identified the patient's serum creatinine level: 8.9 mg/dL.\\n2. Noted the patient's age: 38 years old.\\n3. Since the patient is female, I used the female-specific CKD-EPI equation.\\n4. The CKD-EPI equation for females when Scr > 0.7 mg/dL is: GFR = 144 \u00d7 (Scr / 0.7)^-1.209 \u00d7 0.993^age.\\n5. Substituted the values into the equation:\\n - Scr = 8.9 mg/dL\\n - \u03ba (for females) = 0.7\\n - Age = 38 years\\n6. First, calculated (Scr / \u03ba) = 8.9 / 0.7 \u2248 12.7143.\\n7. Next, computed (12.7143)^-1.209. Using logarithms or a calculator, this is approximately 0.0459.\\n8. Multiplied this result by 144: 144 * 0.0459 \u2248 6.59.\\n9. Then, calculated 0.993^38. Using the approximation ln(0.993) \u2248 -0.00705, and exponentiating, we get approximately 0.765.\\n10. Finally, multiplied the two results together: 6.59 * 0.765 \u2248 5.04.\\nThus, the estimated GFR is approximately 5 mL/min/1.73 m\u00b2.", "LLM Thinking": "Okay, let me try to figure out the patient's GFR using the 2021 CKD-EPI Creatinine equation. First, I need to recall what the formula is. Wait, the CK D-EPI equation is used to estimate GFR based on serum creatinine , age, sex, and race. But the user specified to use the 2021 version, which might be different from the older ones . Hmm, I should make sure I have the correct equation. Looking up the 2021 CKD-EPI creatinine equation: I think it's still similar to the 2009 version but maybe updated with more recent data. Let me confirm. The formula is: For females, if they are non-Hispanic Black , the equation is different, but if not, the standard formula applies. Wait, but the problem might not mention race, so maybe I should assume non-black and non-Hispanic unless stated otherwise. But since the problem doesn't specify, perhaps I can proceed with the standard formula. Let me check. The 2021 CKD-EPI equation for eGFR using creatinine is: For females: If Scr \u2264 0.7 : GFR = 144 \u00d7 (Scr/0.7 )^-0.329 If Scr > 0.7 : GFR = 144 \u00d7 (Scr/0.7 )^-1.209 \u00d7 0.993^ age For males: If Scr \u2264 0.7 : GFR = 141 \u00d7 (Scr/0.7 )^-0 .411 \u00d7 0.993^ age Wait , no, maybe I'm mixing up. Let me get this straight. The standard CKD-EPI equations for males and females are slightly different. For males, the equation is: eGFR (mL/min/ 1.73 m\u00b2) = 141 \u00d7 (Scr /\u03ba)^\u03b1 \u00d7 0.993^age Where \u03ba = 0.9 for men and 0.7 for women , \u03b1 = -0.411 for men and -0. 329 for women if Scr \u2264 \u03ba; otherwise \u03b1 = -1 .209 for men and -1.209 for women . Wait, maybe I need to check the exact coefficients again. Alternatively, perhaps the 2021 version uses the same coefficients but updated with more recent data. Alternatively, perhaps the 2021 equation is the same as the 2009 one but with a different handling of race. Since the question doesn't mention race, maybe we can proceed with the standard formula assuming non-black and non-Hispanic. Looking at the patient's data, the serum creatinine is 8 .9 mg/dL. Wait, that's a very high value. But the CKD-EPI formula uses serum creatinine in mg/dL , so we need to convert that. Wait, the 202 1 CKD-EPI equation uses serum creatinine in mg/dL. So first, we need to get the serum creatinine value from the note . Let me check the note again. The patient's serum creatinine was 8.9 mg/dL. So that's the value we need. Now, the patient is female, so we need to apply the female formula. Let me confirm. The CKD-EPI equation for females is: If Scr \u2264 0 .7 mg/dL, use the first part. If Scr > 0.7, use the second part. Since 8.9 is much higher than 0.7, we use the second part. The formula for females when Scr > 0.7 is: GFR = 144 \u00d7 (Scr/0.7)^-1 .209 \u00d7 0.993^age But wait, let me make sure. The CKD-EPI equation for females is: For females, the equation is: eGFR (mL /min/1.73 m\u00b2) = 144 \u00d7 (Scr / 0.7)^-1.209 \u00d7 0.993^age if Scr > 0.7 . Wait, but I think the exponent for the Scr part is different. Let me double-check the exact formula. From the CKD-EPI guidelines, the equation for females is: For females, the eGFR is calculated as: For Scr \u2264 0 .7: eGFR (mL/min/1.73 m\u00b2) = 144 \u00d7 (Scr/0.7 )^-0.329 For Scr > 0.7 : eGFR = 144 \u00d7 (Scr/0. 7 )^-1.209 \u00d7 0.993 ^age Similarly, for males: For Scr \u2264 0.7 : eGFR = 141 \u00d7 (Scr/0. 9 )^-0.411 For Scr >0.9 : eGFR = 141 \u00d7 (Scr/0. 9 )^-1.209 \u00d7 0.993 ^age Wait, but the cutoff for males is 0.9 , not 0.7. So in this case, since the patient is female, and her Scr is 8.9 mg/dL, which is way above 0.7, we use the second part of the female equation. So substituting into the formula: Scr = 8.9 mg/d L \u03ba = 0.7 (since female) So: e GFR = 144 \u00d7 (8.9 / 0 .7 )^-1.209 \u00d7 0.993^age Now, we need the patient's age. The patient is 38 years old. So age = 38. Let me compute step by step: First, compute (Scr / \u03ba) = 8.9 / 0.7 \u2248 12. 7143 Then, raise that to the power of -1 .209: 12.7143^-1. 209. Let's calculate that. Let me use natural logarithm to compute this. ln(12.7143) = ln(12.7143) \u2248 2. 543 Multiply by -1.209: 2 .543 * (-1.209) \u2248 - 3.076 Then exponentiate: e^-3.0 76 \u2248 e^-3.076 \u2248 0 .0459 (since e^-3 is about 0. 0498, so a bit lower) So (8.9 /0.7)^-1.209 \u2248 0 .0459 Now multiply by 144: 1 44 * 0.0459 \u2248 6. 59 Then multiply by 0.993^age. Age is 38. Compute 0.993^3 8. Let's approximate this. Since each year reduces by a factor of 0.993. Alternatively, take the natural log: ln (0.993) \u2248 -0.007 05 (since ln(1-x) \u2248 -x for small x) So ln(0.993) \u2248 -0 .00705 Multiply by 38: -0 .00705 * 38 \u2248 -0. 2679 Exponentiate: e^-0.26 79 \u2248 0.765 So 0. 993^38 \u2248 0.765 Now multiply the previous result (6.59) by 0 .765: 6.59 * 0.76 5 \u2248 5.04 But wait, let me check if I did the calculations correctly. Let me re-calculate the (Scr/\u03ba)^-1.2 09 part. Scr is 8.9, \u03ba is 0 .7. So 8.9 /0.7 = 1 2.7143. Taking that to the power of -1 .209: 12.7143^-1. 209. Let me use a calculator approach: First, 1 2.7143^(-1.209) = 1 / (12.7143^1.2 09) Compute 12.7143^1. 209: Let me see. Let me compute 12. 7143^1.2. Using logarithms: ln( 12.7143) \u2248 2.54 3 Multiply by 1.209: 2.5 43 *1.209 \u2248 3.07 6 Exponentiate: e^3.076 \u2248 21.7 (since e^3 is about 2 0.085, so 21.7 is reasonable) So 12.7143^1.2 \u2248 21.7. Thus 1/21.7 \ufffd \u2248 0.046. So that part is approximately 0 .046. Then 144 * 0.0 46 = 6.624 Multiply by 0. 993^38. Let me compute 0.99 3^38: Using the formula (1 - 0.0 07)^38 \u2248 e^(-0.007 *38) \u2248 e^-0.266 \u2248 0.766. So 6.624 * 0.766 \u2248 5.07 mL/min /1.73. However, given the high serum creatinine, this seems very low, but considering the patient has severe renal failure (creatinine 8.9 mg/dL is extremely high, which corresponds to a very low GFR , like in acute kidney injury), so a GFR of around 5 mL/min is plausible. Let me cross-verify with another method. Alternatively, the standard CKD-EPI equation for males uses a different \u03ba (0.9) but since the patient is female, we stick to 0.7. Alternatively, maybe I made a mistake in the exponent for the female equation. Let me check again. The CKD-EPI equation for females when Scr > 0.7 is: eGFR = 144 \u00d7 (Scr /0 .7)^-1.209 \u00d7 0.993^age. So that's exactly what I used. So the calculation is correct. Alternatively, perhaps I should use the exact formula coefficients again. Let me confirm the exact coefficients from the 2021 CKD -EPI equation. According to the latest guidelines, the equation for females is: For females, the equation is: eGFR (mL/min/1.7 3 m\u00b2) = 144 \u00d7 (Scr / 0 .7)^a \u00d7 0.993^age, where a = -1.209 if Scr > 0.7 . So that's exactly what I used. So the calculation is correct.", "Ground Truth Answer": "5.366", "Ground Truth Explanation": "The formula for computing GFR is 142 x (Scr/A)**B x 0.9938**age x (gender_coeffcient), where the ** indicates an exponent operation, Scr is the concentration of serum creatinine in mg/dL and gender_coefficient is 1.012 if the patient is female, else the coeffient is 1. The coefficients A and B are dependent on the patient's gender and the patient's creatinine concentration.\nThe patient is 38 years old. The patient's gender is Female, and so the patient's gender coefficient is 1.012.\nThe concentration of Serum Creatinine is 8.9 mg/dL. Because the patient's gender is female and the creatinine concentration is greater than or equal to 0.7 mg/dL, A = 0.7 and B = -1.2.\nPlugging in these values, we get 142 * (8.9/0.7)**-1.2 * 0.9938**38 * 1.012 = 5.366.\nHence, the GFR value is 5.366 ml/min/1.73 m\u00b2.", "Result": "Incorrect", "Thought Type": "ensembled_thought_without_answer", "Transferred Thoughts": "Okay, let me try to figure out the patient's GFR using the 2021 CKD-EPI Creatinine equation.  \nFirst, I need to recall what the formula is.  \nWait, the CK D-EPI equation is used to estimate GFR based on serum creatinine , age, sex, and race.  \nBut the user specified to use the 2021 version, which might be different from the older ones .  \nHmm, I should make sure I have the correct equation.  \nLooking up the 2021 CKD-EPI creatinine equation: I think it's still similar to the 2009 version but maybe updated with more recent data.  \nLet me confirm.  \nThe formula is:\n\nFor females, if they are non-Hispanic Black , the equation is different, but if not, the standard formula applies.  \nWait, but the problem might not mention race, so maybe I should assume non-black and non-Hispanic unless stated otherwise.  \nBut since the problem doesn't specify, perhaps I can proceed with the standard formula.  \nLet me check.  \nThe 2021 CKD-EPI equation for eGFR using creatinine is:\n\nFor females:  \nIf Scr \u2264 0.7 : GFR = 144 \u00d7 (Scr/0.7 )^-0.329  \nIf Scr > 0.7 : GFR = 144 \u00d7 (Scr/0.7 )^-1.209 \u00d7 0.993^ age\n\nFor males:  \nIf Scr \u2264 0.7 : GFR = 141 \u00d7 (Scr/0.7 )^-0 .411 \u00d7 0.993^ age  \nWait , no, maybe I'm mixing up. Let me get this straight. The standard CKD-EPI equations for males and females are slightly different. For males, the equation is:\n\neGFR (mL/min/ 1.73 m\u00b2) = 141 \u00d7 (Scr /\u03ba)^\u03b1 \u00d7 0.993^age\n\nWhere \u03ba = 0.9 for men and 0.7 for women , \u03b1 = -0.411 for men and -0. 329 for women if Scr \u2264 \u03ba; otherwise \u03b1 = -1 .209 for men and -1.209 for women .  \nWait, maybe I need to check the exact coefficients again.  \nAlternatively, perhaps the 2021 version uses the same coefficients but updated with more recent data.  \nAlternatively, perhaps the 2021 equation is the same as the 2009 one but with a different handling of race.  \nSince the question doesn't mention race, maybe we can proceed with the standard formula assuming non-black and non-Hispanic.  \nLooking at the patient's data, the serum creatinine is 8 .9 mg/dL.  \nWait, that's a very high value.  \nBut the CKD-EPI formula uses serum creatinine in mg/dL , so we need to convert that.  \nWait, the 202 1 CKD-EPI equation uses serum creatinine in mg/dL.  \nSo first, we need to get the serum creatinine value from the note . Let me check the note again.  \nThe patient's serum creatinine was 8.9 mg/dL.  \nSo that's the value we need.  \nNow, the patient is female, so we need to apply the female formula.  \nLet me confirm.  \nThe CKD-EPI equation for females is:\n\nIf Scr \u2264 0 .7 mg/dL, use the first part. If Scr > 0.7, use the second part.  \nSince 8.9 is much higher than 0.7, we use the second part.  \nThe formula for females when Scr > 0.7 is:\n\nGFR = 144 \u00d7 (Scr/0.7)^-1 .209 \u00d7 0.993^age\n\nBut wait, let me make sure.  \nThe CKD-EPI equation for females is:\n\nFor females, the equation is:\n\neGFR (mL /min/1.73 m\u00b2) = 144 \u00d7 (Scr / 0.7)^-1.209 \u00d7 0.993^age if Scr > 0.7 .  \nWait, but I think the exponent for the Scr part is different. Let me double-check the exact formula.  \nFrom the CKD-EPI guidelines, the equation for females is:\n\nFor females, the eGFR is calculated as:\n\nFor Scr \u2264 0 .7:\n\neGFR (mL/min/1.73 m\u00b2) = 144 \u00d7 (Scr/0.7 )^-0.329\n\nFor Scr > 0.7 :\n\neGFR = 144 \u00d7 (Scr/0. 7 )^-1.209 \u00d7 0.993 ^age\n\nSimilarly, for males:\n\nFor Scr \u2264 0.7 :\n\neGFR = 141 \u00d7 (Scr/0. 9 )^-0.411\n\nFor Scr >0.9 :\n\neGFR = 141 \u00d7 (Scr/0. 9 )^-1.209 \u00d7 0.993 ^age\n\nWait, but the cutoff for males is 0.9 , not 0.7.  \nSo in this case, since the patient is female, and her Scr is 8.9 mg/dL, which is way above 0.7, we use the second part of the female equation.  \nSo substituting into the formula:\n\nScr = 8.9 mg/d L\n\n\u03ba = 0.7 (since female)\n\nSo:\n\ne GFR = 144 \u00d7 (8.9 / 0 .7 )^-1.209 \u00d7 0.993^age\n\nNow, we need the patient's age.  \nThe patient is 38 years old. So age = 38.\n\nLet me compute step by step:  \nFirst, compute (Scr / \u03ba) = 8.9 / 0.7 \u2248 12. 7143\n\nThen, raise that to the power of -1 .209:  \n12.7143^-1. 209. Let's calculate that. Let me use natural logarithm to compute this.  \nln(12.7143) = ln(12.7143) \u2248 2. 543  \nMultiply by -1.209: 2 .543 * (-1.209) \u2248 - 3.076  \nThen exponentiate: e^-3.0 76 \u2248 e^-3.076 \u2248 0 .0459 (since e^-3 is about 0. 0498, so a bit lower)  \nSo (8.9 /0.7)^-1.209 \u2248 0 .0459  \nNow multiply by 144:  \n1 44 * 0.0459 \u2248 6. 59  \nThen multiply by 0.993^age. Age is 38.  \nCompute 0.993^3 8. Let's approximate this. Since each year reduces by a factor of 0.993.  \nAlternatively, take the natural log:  \nln (0.993) \u2248 -0.007 05 (since ln(1-x) \u2248 -x for small x)  \nSo ln(0.993) \u2248 -0 .00705  \nMultiply by 38: -0 .00705 * 38 \u2248 -0. 2679  \nExponentiate: e^-0.26 79 \u2248 0.765  \nSo 0. 993^38 \u2248 0.765 Now multiply the previous result (6.59) by 0 .765:  \n6.59 * 0.76 5 \u2248 5.04\n\nBut wait, let me check if I did the calculations correctly. Let me re-calculate the (Scr/\u03ba)^-1.2 09 part.  \nScr is 8.9, \u03ba is 0 .7. So 8.9 /0.7 = 1 2.7143.  \nTaking that to the power of -1 .209:  \n12.7143^-1. 209. Let me use a calculator approach:  \nFirst, 1 2.7143^(-1.209) = 1 / (12.7143^1.2 09)  \nCompute 12.7143^1. 209:  \nLet me see. Let me compute 12. 7143^1.2. Using logarithms:  \nln( 12.7143) \u2248 2.54 3  \nMultiply by 1.209: 2.5 43 *1.209 \u2248 3.07 6  \nExponentiate: e^3.076 \u2248 21.7  (since e^3 is about 2 0.085, so 21.7 is reasonable)  \nSo 12.7143^1.2 \u2248 21.7. Thus 1/21.7 \ufffd \u2248 0.046.  \nSo that part is approximately 0 .046.  \nThen 144 * 0.0 46 = 6.624  \nMultiply by 0. 993^38. Let me compute 0.99 3^38:  \nUsing the formula (1 - 0.0 07)^38 \u2248 e^(-0.007 *38) \u2248 e^-0.266 \u2248 0.766.  \nSo 6.624 * 0.766 \u2248 5.07 mL/min /1.73.\n\nHowever, given the high serum creatinine, this seems very low, but considering the patient has severe renal failure (creatinine 8.9 mg/dL is extremely high, which corresponds to a very low GFR , like in acute kidney injury), so a GFR of around 5 mL/min is plausible.  \nLet me cross-verify with another method.  \nAlternatively, the standard CKD-EPI equation for males uses a different \u03ba (0.9) but since the patient is female, we stick to 0.7.  \nAlternatively, maybe I made a mistake in the exponent for the female equation. Let me check again.  \nThe CKD-EPI equation for females when Scr > 0.7 is:  \neGFR = 144 \u00d7 (Scr /0 .7)^-1.209 \u00d7 0.993^age.  \nSo that's exactly what I used.  \nSo the calculation is correct.  \nAlternatively, perhaps I should use the exact formula coefficients again. Let me confirm the exact coefficients from the 2021 CKD -EPI equation.  \nAccording to the latest guidelines, the equation for females is:  \nFor females, the equation is:  \neGFR (mL/min/1.7 3 m\u00b2) = 144 \u00d7 (Scr / 0 .7)^a \u00d7 0.993^age,  \nwhere a = -1.209 if Scr > 0.7 .  \nSo that's exactly what I used.  \nSo the calculation is correct."}
{"Row Number": 449, "Calculator Name": "FeverPAIN Score for Strep Pharyngitis", "Calculator ID": "33", "Category": "diagnosis", "Note ID": "pmc-8610453-1", "Patient Note": "A 77-year-old male with a past medical history significant for hypertension, stroke, and prostate cancer presented to the emergency department for accidental ingestion with nausea and vomiting. Approximately 90 minutes prior to arrival, the patient had gone to the refrigerator for water and had mistaken a bottle of 35% hydrogen peroxide for water, subsequently ingesting approximately 150 milliliters (mL). The patient immediately felt a burning sensation in his mouth and throat, followed by nausea and vomiting. He reportedly vomited several times, mostly dry heaving, but at one point had a small amount of blood in the vomitus. He otherwise denied any other complaints.\nThe patient was in no acute distress upon arrival. His blood pressure was elevated at 157/84 millimeters of mercury, respiratory rate 20 breaths per minute, pulse 65 beats per minute, and arterial oxygen saturation was 98% on room air. Complete physical examination was negative for posterior oropharyngeal erythema, abdominal tenderness, rebound, or guarding. Laboratory results were significant for an elevated leukocyte count of 18.9 \u00d7 103 thousand per millimeters cubed (K/mm3) (reference range: 4.5\u201311.0 K/mm3), hemoglobin of 16.4 grams per deciliter (g/dL) (12.0\u201316.0 g/dL), creatinine of 1.7 milligrams (mg)/dL (0.5\u20131.4 mg/dL), and lipase of 844 U/L (73\u2013393 U/L). Initial imaging via computed tomography (CT) of the abdomen and pelvis with contrast revealed gastric pneumatosis extending into the distal esophagus with extensive portal venous air, diverticulosis, multiple left renal cysts, and a 5.8-centimeter (cm) adrenal myolipoma ().\nGiven the patient\u2019s presenting symptoms combined with the CT findings of gastric pneumatosis, the poison center and gastroenterology were consulted. The patient was admitted for observation with plans for an endoscopy; however, upon surgical consultation, he was emergently transferred to a tertiary care hospital due to concerns for a potential perforation and necrosis of the gastric body and distal esophagus, which may have necessitated a total gastrectomy as well as distal esophagectomy. The patient had been placed on a nothing-by-mouth restriction on admission and was hemodynamically stable on intravenous (IV) fluids, pantoprazole IV drip, and piperacillin-tazobactam at time of transfer.\nUpon arrival at the tertiary center, the patient reported overall improvement of his abdominal pain and sore mouth. Esophagogastroduodenoscopy performed there confirmed moderate to severe distal esophagitis and severe pangastritis but no evidence of necrosis, linear ulcerations along the lesser curvature, or mild bulbar duodenitis. Gastric biopsy later demonstrated fundic type gastric mucosa with acute inflammation and epithelial erosion. Following his endoscopy, the patient tolerated clear liquids and had his diet advanced to surgical soft. He remained pain-free and was deemed stable for discharge on the third day with recommendations for a repeat endoscopy in two to three months.", "Question": "What is the patient's FeverPAIN score?", "LLM Name": "BytedTsinghua-SIA/DAPO-Qwen-32B", "LLM Answer": "3", "LLM Explanation": "To calculate the FeverPAIN score for this patient, I will evaluate each component of the FeverPAIN score based on the information provided in the patient note. The components are: \\n\\n- F (Fever): Temperature \u2265 38\u00b0C.\\n- E (Erythema): Oral, pharyngeal, or esophageal erythema.\\n- P (Perforation): Evidence of perforation (clinical or radiological).\\n- A (Abdominal Pain): Severe abdominal pain.\\n- I (Infiltrates): Pulmonary infiltrates on chest X-ray.\\n- N (Neutrophils): Neutrophil count \u2265 75% of total WBC or absolute neutrophil count \u2265 7.5 \u00d7 10^9/L.\\n\\nNow let's evaluate each component step by step:\\n\\n1. **Fever**: The patient note does not mention any fever or temperature reading. Therefore, this criterion is not met. Score for Fever = 0.\\n\\n2. **Erythema**: The physical examination was negative for posterior oropharyngeal erythema. Therefore, this criterion is not met. Score for Erythema = 0.\\n\\n3. **Perforation**: The CT scan showed gastric pneumatosis extending into the distal esophagus with extensive portal venous air. These findings suggest perforation. Therefore, this criterion is met. Score for Perforation = 1.\\n\\n4. **Abdominal Pain**: The patient presented with nausea and vomiting and later reported improvement in abdominal pain at the tertiary center. Although the initial presentation does not explicitly mention abdominal pain, the presence of nausea and vomiting and the subsequent improvement in abdominal pain suggest that there was some form of abdominal discomfort. Therefore, this criterion is met. Score for Abdominal Pain = 1.\\n\\n5. **Infiltrates**: There is no mention of chest X-ray findings or pulmonary infiltrates. Therefore, this criterion is not met. Score for Infiltrates = 0.\\n\\n6. **Neutrophils**: The white blood cell (WBC) count is elevated at 18.9 \u00d7 10^3 K/mm3 (or 18.9 \u00d7 10^9/L). While the absolute neutrophil count is not provided, an elevated WBC often indicates neutrophilia. Assuming that the majority of the elevated WBC is due to neutrophils, the absolute neutrophil count is likely high. Therefore, this criterion is likely met. Score for Neutrophils = 1.\\n\\nAdding up the scores for the components that are met:\\n- Perforation: 1 - Abdominal Pain: 1 - Neutrophils: 1\\n Total FeverPAIN score = 1 + 1 + 1 = 3.\\n", "LLM Thinking": "Okay, let me try to figure out the FeverPAIN score for this patient. First, I need to remember what the FeverPAIN score is. From what I recall, FeverPAIN is a scoring system used to assess the risk of perforation in patients with suspected peptic ulcer disease. The components are: - F: Fever (temperature \u2265 38\u00b0C ) - E: Erythema (oral, pharyngeal , or esophageal) - P: Perforation (evidence on imaging or clinical suspicion) - A: Abdominal pain - I: Infiltrates on chest X-ray - N: Neutrophils (absolute neutrophil count \u2265 75% of total WBC) - Score is each component present = 1, total score from 0-6. Higher scores indicate higher risk of perforation. But wait, maybe some sources mention different components? Let me double-check. Alternatively, maybe it's F for Fever, E for Erythema, P for Perforation, A for Abdominal pain, I for infiltrates, N for neutrophil percentage, and maybe others like elevated white count? Hmm, I might be mixing up some elements. Alternatively, maybe it's F for fever, E for erythema, P for perforation, A for abdominal pain, I for infiltrates, N for neutrophils, and maybe another component like elevated WBC or something else. Wait, perhaps the FeverPAIN score is actually F for Fever, E for Erythema, P for Perforation, A for Abdominal pain, I for Infiltrates, N for Neutrophils (as in high neutrophil count), and maybe another component like elevated WBC. Wait, I might need to get this right. Alternatively, maybe the FeverPAIN score is a different acronym. Let me check my memory again. Oh right! FeverPAIN might actually be a mnemonic where each letter stands for a component: Fever: Temperature \u226538\u00b0C Erythema: Oral, pharyngeal, or esophageal erythema Perforation: Evidence of perforation (clinical or radiological) Pain: Severe abdominal pain Infiltrates: Pulmonary infiltrates on chest X-ray Neutrophilia: Neutrophil count \u226575% of total WBC (absolute neutrophil count \u22657.5 \u00d710^9/L) So the score is the number of these criteria met. Each criterion present adds 1 point, so maximum 6 points. Higher scores indicate higher risk of perforation. So the steps would be to check if each of these criteria is present in the patient's case. Let me go through each component one by one based on the patient note. First, Fever: The note says the patient was in no acute distress, BP elevated, but there's no mention of fever. The temperature isn't mentioned. Erythema: The physical exam was negative for posterior oropharyngeal erythema. The patient had some burning sensation, but no erythema found on exam. Perforation: The CT showed gastric pneumatosis and portal venous air, which can be signs of perforation. Also, the patient had blood in vomitus, which could indicate perforation. Abdominal pain: The patient had nausea and vomiting, and upon arrival, he was admitted for observation with plans for endoscopy. The tertiary center noted improvement in abdominal pain. However, the initial presentation includes nausea and vomiting, but does the note specifically mention abdominal pain? The initial presentation mentions burning sensation in mouth and throat, nausea, vomiting, and later at the tertiary center, he had improvement in abdominal pain. But when the patient was first seen, the note says \"no acute distress\" but \"otherwise denied any other complaints\" which might mean no abdominal pain? Wait, the note says he was in no acute distress upon arrival, but doesn't explicitly state that he had abdominal pain. However, since the patient was admitted for possible perforation, and the CT showed signs of perforation (pneumatosis, portal venous air), even if not explicitly stated as abdominal pain, the presence of perforation would likely override the absence of explicit abdominal pain. Infiltrates: There's no mention of chest X-ray findings or pulmonary infiltrates. Neutrophils: The lab results show a WBC of 18.9 K/mm3 (high), but the note doesn't specify the percentage of neutrophils. However, in the FeverPAIN score, the component is neutrophils \u226575% of total WBC. Since the WBC is elevated, maybe the neutrophil count is high. But without specific data, can we assume? The question is, do we have enough info? The lab only mentions WBC count, hemoglobin, creatinine, and lipase. The absolute neutrophil count isn't given. However, in the FeverPAIN score, if the WBC is \u226510 K/mm3, does that count as neutrophilia? Wait, the original FeverPAIN criteria might require absolute neutrophil count \u22657.5 \u00d710^9/L, which is equivalent to 75% of total WBC if the WBC is 10. So for example, if WBC is 18.9, and the neutrophils are, say, 80%, then the absolute count would be 15.1, which is way above 7.5. But since the percentage isn't given, we can't be sure. However, maybe the FeverPAIN score just requires a high WBC (\u226510 K/mm3) as a surrogate for neutrophilia? Wait, I need to confirm the exact criteria. Alternatively, maybe the FeverPAIN score requires the absolute neutrophil count to be \u22657.5 \u00d710^9/L, regardless of WBC. Since the WBC is 18.9 K/mm3 (which is 18.9 \u00d710^9/L), if the absolute neutrophil count is \u22657.5 \u00d710^9/L, then that would meet the criterion.", "Ground Truth Answer": "1", "Ground Truth Explanation": "The patient's current FeverPain score is 0.\nWhether the patient has a fever in the past 24 hours is not reported and so we assume that it is absent for the patient. Because of this, we do not increment the score, keeping the current total at 0.\n'The patient is reported to have an absence of cough or coryza and so we increment the score by 1, making the current total 0 + 1 = 1.\nWhether the patient has a symptom onset \u22643 days is not reported and so we assume that it is absent for the patient. Because of this, we do not increment the score, keeping the current total at 1.\nThe patient is reported to not have purulent tonsils and so we do not increment the score, keeping the current total at 1.\nThe patient is reported to not have severe tonsil inflammation and so we do not increment the score, keeping the current total at 1.\nThe patient's FeverPain score is 1 points.", "Result": "Incorrect", "Thought Type": "ensembled_thought_without_answer", "Transferred Thoughts": "Okay, let me try to figure out the FeverPAIN score for this patient.  \nFirst, I need to remember what the FeverPAIN score is.  \nFrom what I recall, FeverPAIN is a scoring system used to assess the risk of perforation in patients with suspected peptic ulcer disease.  \nThe components are:  \n- F: Fever (temperature \u2265 38\u00b0C )  \n- E: Erythema (oral, pharyngeal , or esophageal)  \n- P: Perforation (evidence on imaging or clinical suspicion)  \n- A: Abdominal pain  \n- I: Infiltrates on chest X-ray  \n- N: Neutrophils (absolute neutrophil count \u2265 75% of total WBC)  \n- Score is each component present = 1, total score from 0-6. Higher scores indicate higher risk of perforation.  \nBut wait, maybe some sources mention different components? Let me double-check.  \nAlternatively, maybe it's F for Fever, E for Erythema, P for Perforation, A for Abdominal pain, I for infiltrates, N for neutrophil percentage, and maybe others like elevated white count?  \nHmm, I might be mixing up some elements.  \nAlternatively, maybe it's F for fever, E for erythema, P for perforation, A for abdominal pain, I for infiltrates, N for neutrophils, and maybe another component like elevated WBC or something else.  \nWait, perhaps the FeverPAIN score is actually F for Fever, E for Erythema, P for Perforation, A for Abdominal pain, I for Infiltrates, N for Neutrophils (as in high neutrophil count), and maybe another component like elevated WBC.  \nWait, I might need to get this right.  \nAlternatively, maybe the FeverPAIN score is a different acronym. Let me check my memory again.  \nOh right! FeverPAIN might actually be a mnemonic where each letter stands for a component:  \nFever: Temperature \u226538\u00b0C  \nErythema: Oral, pharyngeal, or esophageal erythema  \nPerforation: Evidence of perforation (clinical or radiological)  \nPain: Severe abdominal pain  \nInfiltrates: Pulmonary infiltrates on chest X-ray  \nNeutrophilia: Neutrophil count \u226575% of total WBC (absolute neutrophil count \u22657.5 \u00d710^9/L)  \nSo the score is the number of these criteria met. Each criterion present adds 1 point, so maximum 6 points.  \nHigher scores indicate higher risk of perforation.  \nSo the steps would be to check if each of these criteria is present in the patient's case.  \n\nLet me go through each component one by one based on the patient note.  \n\nFirst, Fever: The note says the patient was in no acute distress, BP elevated, but there's no mention of fever. The temperature isn't mentioned.  \n\nErythema: The physical exam was negative for posterior oropharyngeal erythema. The patient had some burning sensation, but no erythema found on exam.  \n\nPerforation: The CT showed gastric pneumatosis and portal venous air, which can be signs of perforation. Also, the patient had blood in vomitus, which could indicate perforation.  \n\nAbdominal pain: The patient had nausea and vomiting, and upon arrival, he was admitted for observation with plans for endoscopy. The tertiary center noted improvement in abdominal pain. However, the initial presentation includes nausea and vomiting, but does the note specifically mention abdominal pain? The initial presentation mentions burning sensation in mouth and throat, nausea, vomiting, and later at the tertiary center, he had improvement in abdominal pain. But when the patient was first seen, the note says \"no acute distress\" but \"otherwise denied any other complaints\" which might mean no abdominal pain? Wait, the note says he was in no acute distress upon arrival, but doesn't explicitly state that he had abdominal pain. However, since the patient was admitted for possible perforation, and the CT showed signs of perforation (pneumatosis, portal venous air), even if not explicitly stated as abdominal pain, the presence of perforation would likely override the absence of explicit abdominal pain.  \n\nInfiltrates: There's no mention of chest X-ray findings or pulmonary infiltrates.  \n\nNeutrophils: The lab results show a WBC of 18.9 K/mm3 (high), but the note doesn't specify the percentage of neutrophils. However, in the FeverPAIN score, the component is neutrophils \u226575% of total WBC. Since the WBC is elevated, maybe the neutrophil count is high. But without specific data, can we assume? The question is, do we have enough info? The lab only mentions WBC count, hemoglobin, creatinine, and lipase. The absolute neutrophil count isn't given. However, in the FeverPAIN score, if the WBC is \u226510 K/mm3, does that count as neutrophilia? Wait, the original FeverPAIN criteria might require absolute neutrophil count \u22657.5 \u00d710^9/L, which is equivalent to 75% of total WBC if the WBC is 10. So for example, if WBC is 18.9, and the neutrophils are, say, 80%, then the absolute count would be 15.1, which is way above 7.5. But since the percentage isn't given, we can't be sure. However, maybe the FeverPAIN score just requires a high WBC (\u226510 K/mm3) as a surrogate for neutrophilia? Wait, I need to confirm the exact criteria. Alternatively, maybe the FeverPAIN score requires the absolute neutrophil count to be \u22657.5 \u00d710^9/L, regardless of WBC. Since the WBC is 18.9 K/mm3 (which is 18.9 \u00d710^9/L), if the absolute neutrophil count is \u22657.5 \u00d710^9/L, then that would meet the criterion."}
{"Row Number": 199, "Calculator Name": "QTc Bazett Calculator", "Calculator ID": "11", "Category": "physical", "Note ID": "20", "Patient Note": "Patient has a heart rate of 46 bpm and a QT interval of 330 msec.", "Question": "Using the Bazett Formula for corrected QT interval, what is the patient's corrected QT interval in msec?", "LLM Name": "BytedTsinghua-SIA/DAPO-Qwen-32B", "LLM Answer": "289", "LLM Explanation": "To calculate the corrected QT interval using the Bazett formula, we use the formula: QTc = QT / sqrt(RR), where RR is the R-R interval in seconds. The given data is: QT = 330 msec and the heart rate is 46 bpm. First, we need to calculate the RR interval. The RR interval is the reciprocal of the heart rate in seconds, which is 60 seconds / 46 bpm = 1.3043478 seconds. Next, we need to find the square root of the RR interval. sqrt(1.3043478) \u2248 1.142. Now, we can plug these values into the Bazett formula: QTc = 330 / 1.142 \u2248 289.00175175175175. Rounding this to the nearest whole number gives us approximately 289 msec.", "LLM Thinking": "Okay, so I need to calculate the corrected QT interval using the Baz ett formula for this patient. The given heart rate is 46 bpm and the QT interval is 330 msec. Let me remember how the Bazett formula works . First, the Bazett formula is QTC = QT / sqrt( heart rate). Right, that's the basic formula. But wait, actually, the heart rate is in beats per minute, so I think the formula uses the RR interval instead of the heart rate directly. Oh wait, maybe I need to convert the heart rate to the RR interval first. Because the RR interval is the time between heartbeats. Since the heart rate is beats per minute, the RR interval in seconds would be 60 divided by the heart rate. Let me confirm that. So the formula for the corrected QT interval using Bazett is QTc = QT / sqrt(RR), where RR is the R-R interval in seconds . So first, I need to compute the RR interval. Given the heart rate is 46 bpm, the RR interval (in seconds) is 60 divided by 46. Let me calculate that. 60 divided by 46 is approximately 1. 3043 seconds. Then I take the square root of that. The square root of 1 .3043. Let me compute that. Hmm, sqrt( 1.3043) is around 1.142 , maybe? Let me check with a calculator. 1.14 squared is 1.2996, which is close to 1.3043. So maybe approximately 1.142. Then divide the QT interval by that. So the QT is 330 msec divided by 1.1 42. Let's do that division: 330 divided by 1.142. Let me calculate that. 1.142 times 288 is about 330? Wait, maybe better to do 330 / 1.1 42. Let me do this step by step. 1.142 * 288 = 1.142 * 288. Let's compute 1.1 * 288 = 316.8, and 0.042 * 288 = 12.096 , so total around 328.896, which is close to 330. Hmm, maybe I need a better approximation . Alternatively, use exact decimal places. Let me use more precise calculation. Let me compute RR interval first: 60 / 46 = 1.2 13043478 seconds. So the square root of that. Let me compute sqrt(1.2 13043478). Let's see. The square of 1.1 is 1.21, so sqrt(1.21) is 1.1. But our value is a bit less, 1.21 3. Wait, 1.1 squared is 1.21. Our RR interval is 1.213, so sqrt(1.213) is a bit more than 1.1. Let me compute it as 1.101? Let me do 1.1 squared is 1.21. 1.10 squared is 1.21. 1.10 squared is 1.21. Hmm, maybe better to use calculator steps. Alternatively, perhaps I should use a more accurate method. Alternatively, maybe the original formula uses heart rate directly, but I thought it 's the RR interval. Wait, let me confirm the exact formula. The Bazett formula is QTc = QT / sqrt(heart rate). Wait, some sources say that the formula is QTc = QT / sqrt (heart rate), but others might use the RR interval. Wait, no, actually, the correct formula is QTc = QT / sqrt( RR interval in seconds ), where RR is the R-R interval. Since the heart rate (HR) is in beats per minute, the RR interval in seconds is 60 / HR. So the formula can also be written as QTc = QT / sqrt(60 / HR). Which simplifies to QTc = QT * sqrt(HR / 6 0). Either way, same result. Let me see. Let's proceed step by step. So first, compute RR interval: 60 / 46 = 1.2 13043478 seconds. Then take the square root of that. Let me compute sqrt(1. 213043478). Let's approximate. Let's note that 1.1^2 = 1.21, so 1.1^2 = 1.21. Since 1.213 is slightly larger, the square root will be a bit more than 1.1. Let me try 1. 101^2: (1.1 + 0. 001)^2 = 1.1^2 + 2 *1.1*0.001 + 0.0 01^2 = 1.21 + 0.0 022 + 0.000001 \u2248 1.2122, which is very close to 1 .213. So sqrt(1.213) is approximately 1.101. So sqrt(RR) \u2248 1.101. So then the QTc is 33 0 divided by 1.101. Let me compute 3 30 / 1.101. Let's do this division : 1.101 \u00d7 300 = 3 30.3. So 330 / 1.1 01 is approximately 300 - a little less. Wait, 1.101 \u00d7 299 = 1. 101 \u00d7 300 - 1.101 = 330.3 - 1.103 = 329.797. So 1.10 1 \u00d7 299 \u2248 329.797. But our numerator is 330. So the difference is 0.2 03. So 0.203 / 1.1 03 \u2248 0.184. So total x is 299 + 0.184 \u2248 2 99.184. So approximately 299.2 msec. So the corrected QT interval is approximately 299.2 msec. But let me check this again. Alternatively, perhaps I should use more precise calculation. Alternatively, maybe I can use the formula in another way. Let me see , the Bazett formula is also written as QTc = QT * sqrt(H R/60). Let me try that approach. Let me compute sqrt( HR /60 ), where HR is 4 6. So sqrt(46/60) = sqrt(0 .766666...). The square root of 0.766666 is approximately 0.875. Let me compute sqrt(0.7 66666). Let me note that 0.8 squared is 0.64 , 0.9 squared is 0.81. So sqrt (0.7666) is between 0.8 and 0.9. Let me try 0.87 squared: 0.87 \u00d70.87 = 0.7 569. 0.87^2 = 0. 7569. 0.875 squared is 0 .7656. Because 0.875^2 = (7/8)^2 = 49/64 = 0.765625. So 0.7 65625 is very close to 0.766 6. So sqrt(0.766666) is approximately 0.875. So then QTc = 3 30 * 0.875. Let me compute that. 330 \u00d70.8 = 264. 330 \u00d70.07 = 23.1 . 330 \u00d70.005 = 1.6 5. Adding them up: 264 +23.1 = 287.1 +1.65 = 2 88.75. Wait, that's conflicting with previous calculation. Wait, maybe I made a mistake here. Wait, let me recalculate. Wait, the formula via this method is QTc = QT * sqrt(H R/60). So sqrt(46/60) = sqrt(0 .766666) \u2248 0.875. Then 330 *0.875. Let me compute 330 *0.875. 0.8 75 is 7/8. So 330 *7 /8 = (330 \u00f78)*7. 3 30 \u00f78 is 41.25. 4 1.25 \u00d77 = 288.75. So that gives 288.75 msec. Wait, this contradicts the previous result. Hmm. So now there's a discrepancy. Which approach is correct? Because the two methods should give the same answer. Let me see. Let's verify: Original formula: QTc = QT / sqrt(6 0/HR) = QT / ( sqrt(60)/sqrt(H R) ) = QT * sqrt(HR)/sqrt(60) = QT * sqrt(HR/60). Yes, they are the same. So both approaches should yield the same result . So why the discrepancy in the calculations? Let me re-examine the first approach. In the first approach, I computed sqrt(60 /46) \u22481.103, then 3 30 /1.103 \u2248299.2 . In the second approach, sqrt(HR/60)=0.875, then 330 *0.875=288.75 . These two results differ significantly . So clearly, I made a mistake in one of the calculations. Let me see where the error is. Let me re-calculate the first approach step by step. RR interval is 60/46. Let me compute that again: 60 divided by 46. 46 \u00d71.3 is 59.8, so 1.3 is 46\u00d71.3=59 .8. So 60-59.8=0. 2. So 60/46=1.3 +0 .2/46 \u22481.3 +0.00 43478 \u22481.304347 8. Wait a minute! Wait, I think I messed up earlier. The RR interval is 60 divided by 46, so 60/46 is approximately 1.30 43478 seconds, not 1.213. That was a mistake . So earlier, I incorrectly calculated 60/46 as 1 .213, but actually, 60 divided by 46 is 1.3043. That was the critical error . That explains the discrepancy. So let me start over with correct calculation. Correct RR interval: 60 /46 = 1.3 043478 seconds. Then take the square root of that. Let me compute sqrt(1. 3043478). Let me compute that. Let's see. 1.14^2 = 1.2996. Then, 1.142^2 = ~1.3 0416. So sqrt(1.3043) \u22481.142. 1.142 \u00d7289=330.038, which is very close to 330.", "Ground Truth Answer": "288.985", "Ground Truth Explanation": "The corrected QT interval using the Bazett formula is computed as  QTc = QT interval / \u221a (RR interval), where the QT interval is in msec, and RR interval is given as 60/(heart rate).\nThe patient's heart rate is 46 beats per minute.\nThe QT interval is 330 msec.\nThe RR interval is computed as 60/(heart rate), and so the RR interval is 60/46 = 1.304.\nHence, plugging in these values, we will get 330/\u221a(1.304) = 288.985.\nThe patient's corrected QT interval (QTc) is 288.985 msec. ", "Result": "Correct", "Thought Type": "ensembled_thought_without_answer", "Transferred Thoughts": "Okay, so I need to calculate the corrected QT interval using the Baz ett formula for this patient.  \nThe given heart rate is 46 bpm and the QT interval is 330 msec.  \nLet me remember how the Bazett formula works .  \nFirst, the Bazett formula is QTC = QT / sqrt( heart rate).  \nRight, that's the basic formula.  \nBut wait, actually, the heart rate is in beats per minute, so I think the formula uses the RR interval instead of the heart rate directly.  \nOh wait, maybe I need to convert the heart rate to the RR interval first.  \nBecause the RR interval is the time between heartbeats.  \nSince the heart rate is beats per minute, the RR interval in seconds would be 60 divided by the heart rate.  \nLet me confirm that.  \nSo the formula for the corrected QT interval using Bazett is QTc = QT / sqrt(RR), where RR is the R-R interval in seconds .  \nSo first, I need to compute the RR interval.  \nGiven the heart rate is 46 bpm, the RR interval (in seconds) is 60 divided by 46.  \nLet me calculate that.  \n60 divided by 46 is approximately 1. 3043 seconds.  \nThen I take the square root of that.  \nThe square root of 1 .3043.  \nLet me compute that.  \nHmm, sqrt( 1.3043) is around 1.142 , maybe?  \nLet me check with a calculator.  \n1.14 squared is 1.2996, which is close to 1.3043.  \nSo maybe approximately 1.142.  \nThen divide the QT interval by that.  \nSo the QT is 330 msec divided by 1.1 42.  \nLet's do that division: 330 divided by 1.142.  \nLet me calculate that.  \n1.142 times 288 is about 330?  \nWait, maybe better to do 330 / 1.1 42.  \nLet me do this step by step.  \n1.142 * 288 = 1.142 * 288.  \nLet's compute 1.1 * 288 = 316.8, and 0.042 * 288 = 12.096 , so total around 328.896, which is close to 330.  \nHmm, maybe I need a better approximation .  \nAlternatively, use exact decimal places.  \nLet me use more precise calculation.  \nLet me compute RR interval first: 60 / 46 = 1.2 13043478 seconds.  \nSo the square root of that.  \nLet me compute sqrt(1.2 13043478).  \nLet's see. The square of 1.1 is 1.21, so sqrt(1.21) is 1.1. But our value is a bit less, 1.21 3. Wait, 1.1 squared is 1.21. Our RR interval is 1.213, so sqrt(1.213) is a bit more than 1.1. Let me compute it as 1.101? Let me do 1.1 squared is 1.21. 1.10 squared is 1.21. 1.10 squared is 1.21. Hmm, maybe better to use calculator steps. Alternatively, perhaps I should use a more accurate method. Alternatively, maybe the original formula uses heart rate directly, but I thought it 's the RR interval. Wait, let me confirm the exact formula. The Bazett formula is QTc = QT / sqrt(heart rate). Wait, some sources say that the formula is QTc = QT / sqrt (heart rate), but others might use the RR interval. Wait, no, actually, the correct formula is QTc = QT / sqrt( RR interval in seconds ), where RR is the R-R interval. Since the heart rate (HR) is in beats per minute, the RR interval in seconds is 60 / HR. So the formula can also be written as QTc = QT / sqrt(60 / HR). Which simplifies to QTc = QT * sqrt(HR / 6 0). Either way, same result. Let me see. Let's proceed step by step. So first, compute RR interval: 60 / 46 = 1.2 13043478 seconds. Then take the square root of that. Let me compute sqrt(1. 213043478). Let's approximate. Let's note that 1.1^2 = 1.21, so 1.1^2 = 1.21. Since 1.213 is slightly larger, the square root will be a bit more than 1.1. Let me try 1. 101^2: (1.1 + 0. 001)^2 = 1.1^2 + 2 *1.1*0.001 + 0.0 01^2 = 1.21 + 0.0 022 + 0.000001 \u2248 1.2122, which is very close to 1 .213. So sqrt(1.213) is approximately 1.101. So sqrt(RR) \u2248 1.101. So then the QTc is 33 0 divided by 1.101. Let me compute 3 30 / 1.101. Let's do this division : 1.101 \u00d7 300 = 3 30.3. So 330 / 1.1 01 is approximately 300 - a little less. Wait, 1.101 \u00d7 299 = 1. 101 \u00d7 300 - 1.101 = 330.3 - 1.103 = 329.797. So 1.10 1 \u00d7 299 \u2248 329.797. But our numerator is 330. So the difference is 0.2 03. So 0.203 / 1.1 03 \u2248 0.184. So total x is 299 + 0.184 \u2248 2 99.184. So approximately 299.2 msec. So the corrected QT interval is approximately 299.2 msec. But let me check this again. Alternatively, perhaps I should use more precise calculation. Alternatively, maybe I can use the formula in another way. Let me see , the Bazett formula is also written as QTc = QT * sqrt(H R/60). Let me try that approach. Let me compute sqrt( HR /60 ), where HR is 4 6. So sqrt(46/60) = sqrt(0 .766666...). The square root of 0.766666 is approximately 0.875. Let me compute sqrt(0.7 66666). Let me note that 0.8 squared is 0.64 , 0.9 squared is 0.81. So sqrt (0.7666) is between 0.8 and 0.9. Let me try 0.87 squared: 0.87 \u00d70.87 = 0.7 569. 0.87^2 = 0. 7569. 0.875 squared is 0 .7656. Because 0.875^2 = (7/8)^2 = 49/64 = 0.765625. So 0.7 65625 is very close to 0.766 6. So sqrt(0.766666) is approximately 0.875. So then QTc = 3 30 * 0.875. Let me compute that. 330 \u00d70.8 = 264. 330 \u00d70.07 = 23.1 . 330 \u00d70.005 = 1.6 5. Adding them up: 264 +23.1 = 287.1 +1.65 = 2 88.75. Wait, that's conflicting with previous calculation. Wait, maybe I made a mistake here. Wait, let me recalculate. Wait, the formula via this method is QTc = QT * sqrt(H R/60). So sqrt(46/60) = sqrt(0 .766666) \u2248 0.875. Then 330 *0.875. Let me compute 330 *0.875. 0.8 75 is 7/8. So 330 *7 /8 = (330 \u00f78)*7. 3 30 \u00f78 is 41.25. 4 1.25 \u00d77 = 288.75. So that gives 288.75 msec. Wait, this contradicts the previous result. Hmm. So now there's a discrepancy. Which approach is correct? Because the two methods should give the same answer. Let me see. Let's verify:\n\nOriginal formula: QTc = QT / sqrt(6 0/HR) = QT / ( sqrt(60)/sqrt(H R) ) = QT * sqrt(HR)/sqrt(60) = QT * sqrt(HR/60). Yes, they are the same. So both approaches should yield the same result . So why the discrepancy in the calculations? Let me re-examine the first approach. In the first approach, I computed sqrt(60 /46) \u22481.103, then 3 30 /1.103 \u2248299.2 . In the second approach, sqrt(HR/60)=0.875, then 330 *0.875=288.75 . These two results differ significantly . So clearly, I made a mistake in one of the calculations. Let me see where the error is. Let me re-calculate the first approach step by step. RR interval is 60/46. Let me compute that again: 60 divided by 46. 46 \u00d71.3 is 59.8, so 1.3 is 46\u00d71.3=59 .8. So 60-59.8=0. 2. So 60/46=1.3 +0 .2/46 \u22481.3 +0.00 43478 \u22481.304347 8. Wait a minute! Wait, I think I messed up earlier. The RR interval is 60 divided by 46, so 60/46 is approximately 1.30 43478 seconds, not 1.213. That was a mistake . So earlier, I incorrectly calculated 60/46 as 1 .213, but actually, 60 divided by 46 is 1.3043. That was the critical error . That explains the discrepancy. So let me start over with correct calculation. Correct RR interval: 60 /46 = 1.3 043478 seconds. Then take the square root of that. Let me compute sqrt(1. 3043478). Let me compute that. Let's see. 1.14^2 = 1.2996. Then, 1.142^2 = ~1.3 0416. So sqrt(1.3043) \u22481.142.  \n1.142 \u00d7289=330.038, which is very close to 330."}
{"Row Number": 425, "Calculator Name": "HOMA-IR (Homeostatic Model Assessment for Insulin Resistance)", "Calculator ID": "31", "Category": "lab", "Note ID": "pmc-4864000-2", "Patient Note": "A 14 year old Hispanic female with a 3 year history of type 2 diabetes on once-daily DPP-4 inhibitor Sitagliptin presented for evaluation of morbid obesity with asthma, obstructive sleep apnea, reflux, and irregular menses. She was overweight since preschool age. Family history was notable for type 2 diabetes, obesity, hypertension, hyperlipidemia, and cholelithiasis.\nAt initial preoperative evaluation for bariatric surgery, weight was 129.3kg, height was 154.5cm, and BMI was 54.2kg/m2. Laboratory values were consistent with type 2 diabetes with HbA1c 10.7%, FG 210mg/dL, and 2 hour glucose 378mg/dL, and metabolic syndrome with TG 138mg/dL, HDL 39mg/dL, WC 142cm and elevated BP 120/83 (96th percentile diastolic). Despite Sitagliptin100mg daily, Lantus 28 units daily and Metformin XR 1000mg, HbA1c remained between 9.9% and 10.3% for 6 months. She refused further increase in Metformin dose given gastrointestinal complaints. Sitagliptin was stopped and Exenatide 2mg QW was initiated as adjuvant treatment to Lantus 28 units and Metformin 1000mg daily at weight 131.1kg, BMI 54.4kg/m2, HbA1c 10.2%, and FG 163mg/dl. Within two months of treatment, HbA1c improved to 7.9%. After 6 months, she had sustained glycemic control with HbA1c 8.3% and notable improvements in cardiometabolic parameters including FG (\u221217mg/dl), insulin (\u221226uIU/ml), and TG (\u221212mg/dl). Patient\u2019s weight was 131.5kg on day of gastric sleeve resection surgery with Exenatide QW discontinued following surgery due to normalization of blood glucose levels (HbA1c 5.8%) and weight 118.9kg noted at 2 months postoperatively.", "Question": "What is the patient's HOMA-IR score?", "LLM Name": "BytedTsinghua-SIA/DAPO-Qwen-32B", "LLM Answer": "name 'N' is not defined", "LLM Explanation": "name 'N' is not defined", "LLM Thinking": "Okay, I need to calculate the patient's HOMA-IR score based on the information provided in the note. Let me start by recalling what HOMA-IR is. From what I remember, HOMA-IR stands for Homeostatic Model Assessment of Insulin Resistance. It's a formula used to estimate insulin resistance using fasting glucose and fasting insulin levels. The formula is usually (Fasting Insulin (muU/mL) * Fasting Glucose (mmol/L)) / 22.5. Wait, but sometimes the units can vary depending on the source. Let me double-check that. Oh right, the standard formula uses fasting insulin in microunits per mL (\u03bcU/mL) and fasting glucose in mmol/L, and the constant is 22.5. So if the glucose is given in mg/dL, I need to convert it to mmol/L first because the formula requires glucose in mmol/L. Looking at the patient's data: The note mentions her fasting glucose (FG) was 163 mg/dL when she was on Exenatide. Wait, but when was the insulin level measured? The problem mentions \"insulin (\u221226uIU/ml)\" after 6 months of treatment, but I'm not sure if that's the actual value or the change from before. Let me parse the note again. The note states: \"After 6 months, she had sustained glycemic control with HbA1c 8.3% and notable improvements in cardiometabolic parameters including FG (\u221217mg/dl), insulin (\u221226uIU/ml), and TG (\u221212mg/dl).\" So the insulin level decreased by 26 uIU/mL from some baseline, but the actual current insulin level isn't given. Hmm, this is a problem. Because to calculate HOMA-IR, we need both fasting glucose and fasting insulin at the same time. The note doesn't provide the actual fasting insulin level at the time when the glucose was 163 mg/dL. Instead, it says the insulin level decreased by 26 uIU/mL after 6 months. But without the baseline insulin value, I can't compute the current insulin level. Wait, maybe the initial data has some insulin level? Let me check the initial labs. The initial labs at preoperative evaluation mention HbA1c 10.7%, FG 210 mg/dL, and 2-hour glucose 378 mg/dL. But there's no mention of fasting insulin there. Later, when they stopped Sitagliptin and started Exenatide, the HbA1c was 10.2% and FG 163 mg/dL. The note mentions insulin (\u221226uIU/ml) after 6 months, which suggests that at that point, the insulin was lower than before, but the exact value isn't given. Since the problem is asking for HOMA-IR, but the necessary data (fasting insulin) isn't provided in the note, maybe I missed something. Let me go through the note again carefully. The only insulin numbers mentioned are the \"insulin (\u221226uIU/ml)\" as a change, and in the surgery part, after stopping Exenatide, the HbA1c normalized to 5.8% and weight dropped to 118.9 kg at 2 months post-op. Still no fasting insulin value. Hmm. Wait, perhaps the question expects using the FG value at a certain point and assumes that the insulin level is given as a change? For example, maybe the insulin level was 26 uIU/mL below baseline, so maybe that is the actual insulin. But that's flawed.", "Ground Truth Answer": "13.481", "Ground Truth Explanation": "The formula for computing HOMA-IR score is (insulin (\u00b5IU/mL) * glucose mg/dL)/405.\nThe concentration of insulin is 26.0 \u00b5IU/mL.\nThe concentration of glucose is 210.0 mg/dL. \nPlugging into the formula will give us 26.0 * 210.0/405 = 13.481. Hence, the patient's HOMA-IR score is 13.481. ", "Result": "Incorrect"}
{"Row Number": 108, "Calculator Name": "Calcium Correction for Hypoalbuminemia", "Calculator ID": "7", "Category": "lab", "Note ID": "pmc-8342167-1", "Patient Note": "A 26-year-old African American female with a medical history of SLE, ESRD due to LN, remote history of Steven\u2013Johnson Syndrome due to sulfa allergy, and resistant hypertension presented to the emergency department with painful, peeling, blistering, rash and fever. She reported that the rash developed over a period of 3 months with an intermittent response to prednisone therapy. Three weeks prior to presentation, the rash became progressively worse. She developed fevers came on one week prior to presentation. The rash started on her arms and progressively spread. She admitted associated shortness of breath accompanied by a productive cough with green, bloody sputum, as well as nausea and vomiting. Patient reported compliance with her home dose of prednisone but may have not taken her mycophenolate mofetil regularly. She missed two sequential hemodialysis sessions due to pain with walking from the blistering rash on her soles of the feet.\nHer physical exam was significant for fever of 100.6\u00b0F and tachycardia with heart rate of 130 beats per minute. Skin exam was evident for brown plaques on the forehead and bilateral cheeks with sparing of the nasolabial folds, with erosions and hemorrhagic crust involving the philtrum, ears, forehead, nose, chin, and lips. There were dark brown plaques with few erosions and atrophic scars on bilateral forearms and lower legs with deep red to violaceous painful targetoid lesions on the palms and plantar surfaces (Figures and ). The skin over the trunk had pink eroded macules, and there were pink patches on the back within a background of dusky necrotic plaques. There were multiple full-thickness epidermal necroses with large areas of bleeding with the denuded skin on the arms and chest in the sun exposed distribution (). Oral mucosae were negative for any oral lesions.\nPatient was found to be pancytopenic with white blood cell count (WBC) 2.03 (Ref: 3.4\u201310.8 \u00d7 103/UL), absolute neutrophil count (ANC) of 1.25 (Ref: 1.4\u20137.0 \u00d7 103/UL), hemoglobin (Hb) 8.8 g/dL (Ref: 11.1\u201315.9 g/dL), hematocrit (Hct) 28.9% (Ref: 34\u201346%), platelet 69 (150\u2013450 \u00d7 103/UL), sodium 138 mmol/L, potassium 3.9 mmol/L, chloride 98 mmol/L, CO2 21 mmol/L, BUN 41 mg/dL (Ref: 6\u201320 mg/dL), Cr 5.49 mg/dL (Ref: 0.57\u20131.0 mg/dL), calcium 7.2 mg/dL (8.7\u201310.2 mg/dL), albumin 3.2 g/dL, phosphorous 5.0 mg/dL (Ref: 1.2\u20132.2 mg/dL), AST 286 IU/L (Ref 0\u201340 IU/L), ALT 31 IU/L (0\u201332 IU/L), total bilirubin 0.5 mg/dL, alkaline phosphatase 136 IU/L, CK 91 U/L, serum lactate was 0.80 mmol/L, and ferritin was 5885 ng/mL (Ref: 15\u201350 ng/mL). Electrocardiogram was consistent with sinus tachycardia. Chest X-ray did not show any lung infiltrates or effusions. Ultrasound of the abdomen did not show an acute abdominal process, and the liver demonstrated normal echogenicity, echotexture, and size; the spleen was not enlarged. Sputum gram stain and cultures were unremarkable. Blood cultures were negative for bacteria and yeast. Patient was anuric due to chronic dialysis. Evaluation of lupus activity showed double-stranded DNA (dsDNA) antibody 42 IU/mL (Ref: 0\u20139 IU/L). Complement 3 (C3) was 43 mg/dL (Ref: 90\u2013180 mg/dL) and complement 4 (C4) was 9 mg/dL (Ref: 10\u201340 mg/dL). Rheumatoid factor was negative. Sjogren's anti-SSA was >8.0 AI (Ref: 0\u20130.9 AI) and Sjogren's anti-SSB was <0.2 AI (Ref: 0\u20130.9 AI). HIV screen was negative, and viral hepatitis panels for hepatitis A, B, and C were negative. Skin biopsies showed focal interface changes, and periodic acid Schiff (PAS) stain was negative for fungal microorganisms. Gram stain highlighted surface cocci bacteria. VZV and herpes I/II immunostains were negative. The direct immunofluorescence revealed that finely granular deposition of C3, IgM, and fibrinogen is consistent with lupus.\nGiven her presentation of a fever, shortness of breath, and productive cough, there was a concern for postinfectious erythema multiforme. The nucleic acid amplification tests for multiple respiratory pathogens such as Mycoplasma, influenza A, influenza H1, influenza H3, influenza A virus H1 2009, influenza B, respiratory syncytial virus, parainfluenza virus type 1, 2, 3, 4, human metapneumovirus, rhinovirus/enterovirus, adenovirus, Chlamydia pneumoniae, and Mycoplasma pneumoniae were negative. Blood cultures did not grow any bacteria or fungal organisms. Skin wound cultures were also negative for any organisms except for skin flora. Historically, there were no preceding infections reported. Our presumptive primary diagnosis was acute on chronic cutaneous lupus with epidermal necrolysis due to noncompliance with medications; differentials included Rowell syndrome, bullous lupus, Steven\u2013Johnsons syndrome, and toxic epidermal necrolysis (TEN). Hemophagocytic lymphohistiocytosis/mast cell activation syndrome (HLH/MAS) was also a concern given pancytopenia, fevers, elevated transaminases, and elevated ferritin. However, after further evaluation by hematology, HLH/MAS was less likely given halving of ferritin after first dose of intravenous steroids, lack of hepatosplenomegaly, lack of elevation in bilirubin and triglycerides, patient did not have persistent fevers, and soluble IL-2 receptor was 2021 pg/mL (Ref: 175.3\u2013858.2 pg/mL), needed to be greater than 2400 pg/mL (greater than 2 standard deviations of reference range) to meet criteria, and clinical picture was also not as critical as usually seen. The clinical picture of atypical EM-like lesions, presence of chilblains, speckled ANA pattern, elevated anti-Ro/SSA, and absence of infectious or pharmacologic triggers in a patient with SLE confirmed our suspicion for Rowell syndrome.\nDue to the extensive skin surface area involvement, the patient was treated with vancomycin intravenously for primary and secondary skin infection. Gram-negative coverage was held due to severe allergy to penicillin and cephalosporin antibiotics. The pancytopenia was suspected due to an acute flare of systemic lupus erythematosus, and the patient was initially started on methylprednisolone 1.5 mg/kg intravenously daily. Given more than 60% of body surface area (BSA) involvement, the patient was transferred to the burn unit for extensive debridement and multifaceted wound care. Mycophenolate mofetil was held given the elevated transaminases. Pulse doses of intravenous methylprednisolone were escalated to 1000 mg intravenous daily for three days given the concern for acute cutaneous lupus erythematosus with epidermal necrosis and concomitant MAS. After normalization of transaminases, negative testing for latent tuberculosis and hepatitis B and C, and negative blood cultures, the patient was given rituximab 375 mg/m2 intravenously at day 0 and day 15 with excellent maintenance of remission of skin disease and cytopenias. This dose was chosen by the treating provider, given patient being dialysis dependent, thus more immunosuppressed state at baseline and recent elevation in transaminases.\nIt was reassuring that early suspicion for MAS appeared steroid-responsive to pulse intravenous methylprednisolone. The soluble IL-2 receptor alpha measurement was not elevated, and serum ferritin halved after the first dose of pulse steroids. Despite the improvements in serum and systemic symptoms, the skin manifestations were slow to respond. During 2-week and 12-week follow-up of the patient, there has been maintenance of clear skin without any active cutaneous lupus manifestations. Systemic Lupus Erythematosus Disease Activity Index 2000 (SLEDAI-2K) was 0 at 12-week follow-up.", "Question": "Using the Calcium Correction for Hypoalbuminemia formula, what is the patient's corrected calcium in mg/dL? Your may set your normal albumin concentration to be 4 g/dL.", "LLM Name": "BytedTsinghua-SIA/DAPO-Qwen-32B", "LLM Answer": "7.84", "LLM Explanation": "To calculate the corrected calcium using the Calcium Correction for Hypoalbuminemia formula, we use the formula: Corrected Calcium = Measured Calcium + 0.8 * (Normal Albumin - Measured Albumin). Given the patient's measured calcium is 7.2 mg/dL and the measured albumin is 3.2 g/dL, and the normal albumin concentration is set to 4 g/dL. Plugging in the values: 1. Calculate the difference between the normal albumin and the measured albumin: 4 - 3.2 = 0.8 g/dL. 2. Multiply this difference by 0.8: 0.8 * 0.8 = 0.64 mg/dL. 3. Add this result to the measured calcium: 7.2 + 0.64 = 7.84 mg/dL. Thus, the corrected calcium is 7.84 mg/dL.", "LLM Thinking": "Okay, let me try to figure out the corrected calcium level using the Calcium Correction for Hypoalbuminemia formula. The problem states that the patient's albumin is 3.2 g /dL, and we can assume a normal albumin concentration of 4 g/dL. The patient's total calcium level is given as 7.2 mg/d L. First, I need to recall the formula for calcium correction. From what I remember, the formula adjusts the serum calcium based on the album in level because albumin is a major carrier of calcium in the blood. The formula is usually: Corrected Calcium = Measured Calcium + 0 .8 * (Normal Albumin - Measured Albumin). But wait, sometimes it's calculated as measured calcium plus 0.8 times the difference between normal albumin and the patient's albumin. Let me double-check that. Yes, the standard formula is Corrected Total Calcium = Serum Calcium + (0.8 \u00d7 (4.0 - Measured Albumin)). The 0.8 comes from the fact that for every 1 g /dL decrease in albumin, calcium decreases by 0.8 mg /dL. So since the patient's albumin is low, the corrected calcium should be higher than the measured value to account for the lower protein-bound calcium. Plugging in the numbers: the measured calcium is 7.2 , the measured albumin is 3.2, and the normal album in is 4.0. So the difference is 4.0 -3.2 =0.8. Multiply that by 0. 8 gives 0.64. Then add that to the measured calcium : 7.2 +0.64 = 7.8 4. Wait, but let me confirm if the formula is correct here. Alternatively, sometimes the formula might use 0.8 or 0 .9, but in most cases, it's 0.8. Since the question says to use normal albumin of 4 g /dL , which is standard, this should be right. Let me check again the numbers: albumin is 3.2 , so the deficit is 0.8. 0.8 times 0.8 is 0.64. Adding that to 7 .2 gives 7.84. That seems right. But I should also check if there are any other factors here. The question doesn't mention any other conditions, like in the case of hypoalbumin emia leading to higher free calcium, which is why the correction is done. The formula accounts for the bound calcium, so the corrected calcium is adjusted to what it would be at normal albumin levels, making it a better indicator of the true calcium level. But the problem says to use normal albumin as 4 g /dL, so that's exactly what I did. The problem doesn't specify rounding, so perhaps present it as 7. 84. But in some contexts, they might round to one decimal place, making it 7.8. However, since the original calcium is given to one decimal, but the albumin is also 3.2 , which is one decimal, perhaps the answer should be 7.8 4. Let me check the formula once more. Yes, the formula is Corrected Ca = Measured Ca + 0.8*(4 - measured albumin). So 7.2 +0.8*(0.8) = 7.2 + 0.64 =7 .84. The problem may want it to one decimal, so 7.8, but since the original data has two decimals (7.2 and 3 .2), perhaps the answer should be 7.84. Let me check the question again. It says, \"using the Calcium Correction for Hypoalbuminemia formula ,\" and the user says \"your may set your normal albumin concentration to be 4 g/dL.\" So they are giving us the normal album in, so we can proceed with that. But in the problem statement, the calcium is written as 7.2 mg/dL, and albumin is 3.2. So the exact calculation is 7.2 + 0.8*(4 - 3.2) =7.2 +0.8*0. 8=7.2+0.64=7.84 . So that's correct.", "Ground Truth Answer": "7.84", "Ground Truth Explanation": "To compute the patient's correct calcium level in mg/dL, the formula is  (0.8 * (Normal Albumin (in g/dL) - Patient's Albumin (in g/dL))) + Serum Calcium (in mg/dL).\nThe patient's normal albumin level is 4.0 g/dL.\nThe concentration of Albmumin is 3.2 g/dL. \nThe concentration of Calcium is 7.2 mg/dL. \nPlugging these values into the formula, we get (0.8 * (4.0 g/dL - 3.2 g/dL)) + 7.2 mg/dL = 7.84 mg/dL.\nThe patient's corrected calcium concentration 7.84 mg/dL.", "Result": "Correct", "Thought Type": "ensembled_thought_without_answer", "Transferred Thoughts": "Okay, let me try to figure out the corrected calcium level using the Calcium Correction for Hypoalbuminemia formula.  \nThe problem states that the patient's albumin is 3.2 g /dL, and we can assume a normal albumin concentration of 4 g/dL.  \nThe patient's total calcium level is given as 7.2 mg/d L.  \n\nFirst, I need to recall the formula for calcium correction.  \nFrom what I remember, the formula adjusts the serum calcium based on the album in level because albumin is a major carrier of calcium in the blood.  \nThe formula is usually: Corrected Calcium = Measured Calcium + 0 .8 * (Normal Albumin - Measured Albumin).  \nBut wait, sometimes it's calculated as measured calcium plus 0.8 times the difference between normal albumin and the patient's albumin.  \nLet me double-check that.  \n\nYes, the standard formula is Corrected Total Calcium = Serum Calcium + (0.8 \u00d7 (4.0 - Measured Albumin)).  \nThe 0.8 comes from the fact that for every 1 g /dL decrease in albumin, calcium decreases by 0.8 mg /dL.  \nSo since the patient's albumin is low, the corrected calcium should be higher than the measured value to account for the lower protein-bound calcium.  \nPlugging in the numbers: the measured calcium is 7.2 , the measured albumin is 3.2, and the normal album in is 4.0.  \nSo the difference is 4.0 -3.2 =0.8.  \nMultiply that by 0. 8 gives 0.64.  \nThen add that to the measured calcium : 7.2 +0.64 = 7.8 4.  \nWait, but let me confirm if the formula is correct here.  \nAlternatively, sometimes the formula might use 0.8 or 0 .9, but in most cases, it's 0.8.  \nSince the question says to use normal albumin of 4 g /dL , which is standard, this should be right.  \nLet me check again the numbers: albumin is 3.2 , so the deficit is 0.8.  \n0.8 times 0.8 is 0.64.  \nAdding that to 7 .2 gives 7.84.  \nThat seems right.  \n\nBut I should also check if there are any other factors here.  \nThe question doesn't mention any other conditions, like in the case of hypoalbumin emia leading to higher free calcium, which is why the correction is done.  \nThe formula accounts for the bound calcium, so the corrected calcium is adjusted to what it would be at normal albumin levels, making it a better indicator of the true calcium level.  \nBut the problem says to use normal albumin as 4 g /dL, so that's exactly what I did.  \nThe problem doesn't specify rounding, so perhaps present it as 7. 84.  \nBut in some contexts, they might round to one decimal place, making it 7.8.  \nHowever, since the original calcium is given to one decimal, but the albumin is also 3.2 , which is one decimal, perhaps the answer should be 7.8 4.  \n\nLet me check the formula once more.  \nYes, the formula is Corrected Ca = Measured Ca + 0.8*(4 - measured albumin).  \nSo 7.2 +0.8*(0.8) = 7.2 + 0.64 =7 .84.  \nThe problem may want it to one decimal, so 7.8, but since the original data has two decimals (7.2 and 3 .2), perhaps the answer should be 7.84.  \n\nLet me check the question again.  \nIt says, \"using the Calcium Correction for Hypoalbuminemia formula ,\" and the user says \"your may set your normal albumin concentration to be 4 g/dL.\"  \nSo they are giving us the normal album in, so we can proceed with that.  \nBut in the problem statement, the calcium is written as 7.2 mg/dL, and albumin is 3.2.  \nSo the exact calculation is 7.2 + 0.8*(4 - 3.2) =7.2 +0.8*0. 8=7.2+0.64=7.84 .  \nSo that's correct."}
{"Row Number": 712, "Calculator Name": "Adjusted Body Weight", "Calculator ID": "62", "Category": "physical", "Note ID": "pmc-7509996-1", "Patient Note": "A 55-year-old man who suffered from hematochezia for 3 mo consulted our hospital in July 2016 (Figure ).\nThe pathological diagnosis following biopsy showed \u201cmoderately differentiated adenocarcinoma of the sigmoid colon\u201d (Figure ). Abdominal enhanced computed tomography (CT) showed mesenteric lymph node metastasis and multiple low-density lesions in the liver. The capecitabine plus oxaliplatin (XELOX) scheme was recommended for the neoadjuvant therapy regimen for three cycles. However, even with therapy, the evaluation was progressive disease (PD) given that lymph node and liver lesions continued to grow; thus, surgery was excluded.\nFrom February 2 to October 14, 2017, folinic acid, fluorouracil, and irinotecan (FOLFIRI) plus bevacizumab was implemented for 12 cycles, and the classification was stable disease (SD); bevacizumab plus S-1 was offered as the maintenance treatment. On March 30, 2018, CT indicted disease progression. Due to intestinal obstruction, the patient underwent laparoscopic intestinal adhesion lysis and transverse colostomy on May 30, 2018.\nThe patient had no medical history of past illness.\nThe patient neither smoke tobacco nor consume alcohol. There was no notable family medical history, such as cancer.\nThe height and weight of the patient were 160 cm and 56.8 kg, respectively. On July 15, 2018, the performance status (PS) was 1 for this patient, with a body temperature of 36.3 \u00b0C, pulse rate of 86 beats/min, and blood pressure of 152/96 mmHg.\nIn July 2016, immunohistochemistry (IHC) and polymerase chain reaction (PCR) were performed to guide therapy at diagnosis. Kirsten rat sarcoma 2 viral oncogene homolog (KRAS), neuroblastoma RAS Viral Oncogene Homolog (NRAS), and v-raf murine sarcoma viral oncogene homolog B1 (BRAF) were wild-type, and mismatch repair proteins were proficient. On May 29, 2018, a peripheral blood sample was assessed for circulating tumor DNA (ctDNA) using next-generation sequencing (NGS) with an array of 189 genes to determine whether ras-rat sarcoma viral oncogene homolog/v-raf-murine sarcoma viral oncogene homolog (RAS/RAF) status changed during the past 2 years and EGFR monoclonal antibody could be used as the third-line therapy. The test results showed that KRAS, NRAS, and BRAF were still wild-type. Interestingly, high-level amplification of HER2 (absolute copy number: 63.67) (Figure ) was identified at the same time, which was reported as the resistance mechanism of anti-EGFR therapy previously[-]. Also, adenomatous polyposis coli (APC) and tumor protein 53 (TP53) alterations were detected, with a mutant allele frequency (MAF) of 7.3% and 9.3%, respectively. IHC for HER2 showed a score of 3+ based on the tumor tissue biopsy obtained on July 22, 2016 (Figure ), while fluorescence in situ hybridization (FISH) showed high-level amplification of HER2 (Figure ); thus, the two tests confirmed the results of ctDNA.\nOn March 30, 2018, CT showed that most of the liver lesions were increased compared to January 17, 2018, while new, multiple lesions were detected in the lung. Thus, the classification was PD, and the patient failed to respond to two lines of therapy.", "Question": "Using the adjusted body weight formula, what is the patient's adjusted body weight in terms of kg?", "LLM Name": "BytedTsinghua-SIA/DAPO-Qwen-32B", "LLM Answer": "56.91", "LLM Explanation": "To calculate the adjusted body weight (ABW), we first need to determine the ideal body weight (IBW). The patient's height is 160 cm, and the weight is 56.8 kg. We convert the height from cm to inches: 160 cm / 2.54 cm/inch \u2248 62.99 inches. Using the formula for IBW for men: IBW = 50 kg + 2.3 kg * (height in inches - 60 inches), we get: IBW = 50 kg + 2.3 kg * (62.99 - 60) = 50 kg + 2.3 * 2.99 \u2248 50 + 6.877 = 56.877 kg. The patient's actual weight is 56.8 kg, which is slightly less than the IBW (56.877 kg), indicating that the patient is slightly underweight. For underweight patients, the formula for adjusted body weight is: ABW = IBW + 0.4 * (IBW - actual weight). Plugging in the values, we get: ABW = 56.877 + 0.4 * (56.877 - 56.8) = 56.877 + 0.4 * 0.077 \u2248 56.877 + 0.0308 = 56.9078 kg. Rounding this to two decimal places gives us approximately 56.91 kg.", "LLM Thinking": "Okay, let me try to figure this out. The question is asking for the patient's adjusted body weight using the adjusted body weight formula. First, I need to recall what the adjusted body weight formula is. From what I remember, adjusted body weight (ABW) is calculated to account for patients who are underweight or have a low body weight, which might affect drug dosing. The formula typically uses the ideal body weight (IBW) as a reference. The standard formula for IBW is different for men and women. For men, it's 50 kg plus 2.3 kg for each inch over 5 feet. Wait, but maybe I should check the exact formula here. Alternatively, some sources use a different method, like IBW for men: 50 kg + 2.3 kg per inch over 5 feet. So if someone is taller than 5 feet, you add 2.3 kg for each inch above that. Looking at the patient's height: 160 cm. Let me convert that to inches because the formula uses inches. Since 1 inch is about 2.54 cm, 160 divided by 2.54 is approximately 62.99 inches, which is roughly 5 feet 3 inches (since 5 feet is 60 inches, so 2.99 inches extra). Wait, that might be a miscalculation. Let me do it again: 160 cm divided by 2.54 cm per inch equals 62.99 inches. Then subtract 60 inches (which is 5 feet) to get 2.99 inches over 5 feet. So for a man, the IBW would be 50 kg + (2.3 kg per inch * 2.99 inches). Let me compute that: 2.3 * 3 is about 6.9, but since it's 2.99, maybe 2.3*3=6.9, but 0.99 less: 2.3*(3-0.01)=2.3*3 - 2.3*0.01=6.9-0.023=6.877. But wait, maybe the formula is 50 kg plus 2.3 kg per inch over 5 feet. Now, the adjusted body weight (ABW) formula is usually ABW = IBW + 0.4*(current weight - IBW) if the patient's actual weight is more than IBW. But sometimes the formula is ABW = IBW + 0.4*(IBW - current weight) if the current weight is below IBW. Wait, I need to be careful here. Let me think again. The adjusted body weight for underweight patients is typically calculated as IBW plus 0.4 times the difference between IBW and actual weight. Let me check standard formulas. Alternatively, some sources say that for underweight patients, ABW is calculated as IBW + 0.4*(actual weight - IBW), but that would be negative. Let me think of an example. Alternatively, the standard adjusted body weight formula for patients who are overweight is: ABW = IBW + 0.4*(actual weight - IBW) if actual weight > IBW. If actual weight < IBW, then ABW = IBW + 0.4*(IBW - actual weight). Wait, that seems possible. Let me verify. This is confusing.", "Ground Truth Answer": "56.849", "Ground Truth Explanation": "The patient's gender is Male.\nThe patient's height is 160.0 cm, which is 160.0 cm * 0.393701 in/cm = 62.992 in. \nFor males, the ideal body weight (IBW) is calculated as follows:\nIBW = 50 kg + 2.3 kg * (height (in inches) - 60)\nPlugging in the values gives us 50 kg + 2.3 kg * (62.992 (in inches) - 60) = 56.882 kg.\nHence, the patient's IBW is 56.882 kg.The patient's weight is 56.8 kg. To compute the ABW value, apply the following formula: ABW = IBW + 0.4 * (weight (in kg) - IBW (in kg)). ABW = 56.882 kg + 0.4 * (56.8 kg  - 56.882 kg) = 56.849 kg. The patient's adjusted body weight is 56.849 kg.", "Result": "Correct", "Thought Type": "ensembled_thought_without_answer", "Transferred Thoughts": "Okay, let me try to figure this out.  \nThe question is asking for the patient's adjusted body weight using the adjusted body weight formula.  \nFirst, I need to recall what the adjusted body weight formula is.  \nFrom what I remember, adjusted body weight (ABW) is calculated to account for patients who are underweight or have a low body weight, which might affect drug dosing.  \nThe formula typically uses the ideal body weight (IBW) as a reference.  \n\nThe standard formula for IBW is different for men and women.  \nFor men, it's 50 kg plus 2.3 kg for each inch over 5 feet.  \nWait, but maybe I should check the exact formula here.  \nAlternatively, some sources use a different method, like IBW for men: 50 kg + 2.3 kg per inch over 5 feet.  \nSo if someone is taller than 5 feet, you add 2.3 kg for each inch above that.  \nLooking at the patient's height: 160 cm.  \nLet me convert that to inches because the formula uses inches.  \nSince 1 inch is about 2.54 cm, 160 divided by 2.54 is approximately 62.99 inches, which is roughly 5 feet 3 inches (since 5 feet is 60 inches, so 2.99 inches extra).  \nWait, that might be a miscalculation.  \nLet me do it again: 160 cm divided by 2.54 cm per inch equals 62.99 inches.  \nThen subtract 60 inches (which is 5 feet) to get 2.99 inches over 5 feet.  \n\nSo for a man, the IBW would be 50 kg + (2.3 kg per inch * 2.99 inches).  \nLet me compute that: 2.3 * 3 is about 6.9, but since it's 2.99, maybe 2.3*3=6.9, but 0.99 less: 2.3*(3-0.01)=2.3*3 - 2.3*0.01=6.9-0.023=6.877.  \nBut wait, maybe the formula is 50 kg plus 2.3 kg per inch over 5 feet.  \n\nNow, the adjusted body weight (ABW) formula is usually ABW = IBW + 0.4*(current weight - IBW) if the patient's actual weight is more than IBW.  \nBut sometimes the formula is ABW = IBW + 0.4*(IBW - current weight) if the current weight is below IBW.  \nWait, I need to be careful here.  \nLet me think again.  \nThe adjusted body weight for underweight patients is typically calculated as IBW plus 0.4 times the difference between IBW and actual weight.  \nLet me check standard formulas.  \nAlternatively, some sources say that for underweight patients, ABW is calculated as IBW + 0.4*(actual weight - IBW), but that would be negative.  \nLet me think of an example.  \nAlternatively, the standard adjusted body weight formula for patients who are overweight is: ABW = IBW + 0.4*(actual weight - IBW) if actual weight > IBW.  \nIf actual weight < IBW, then ABW = IBW + 0.4*(IBW - actual weight).  \nWait, that seems possible. Let me verify.  \nThis is confusing."}
{"Row Number": 1021, "Calculator Name": "Estimated of Conception", "Calculator ID": "68", "Category": "date", "Note ID": "14", "Patient Note": "The patient's last menstrual period was on 02/08/2024. Her cycle length is 25 days.", "Question": "Based on the patient's last menstrual period and cycle length, what is the the patient's estimated date of conception? Your answer should be in the format of M/D/Y (ie 08/31/2023, 07/03/2000) with just the date and not other text. ", "LLM Name": "BytedTsinghua-SIA/DAPO-Qwen-32B", "LLM Answer": "time data 'N/A' does not match format '%m/%d/%Y'", "LLM Explanation": "time data 'N/A' does not match format '%m/%d/%Y'", "LLM Thinking": "Okay, so I need to figure out the estimated date of conception based on the patient's last menstrual period (LMP) and cycle length. Let me think through this step by step. First, I remember that typically, pregnancy is calculated from the first day of the LMP. The standard assumption is that ovulation occurs around two weeks after the LMP, which would be around day 14 of a 28-day cycle. But here, the cycle length is 25 days, which is shorter than the average 28. So, maybe the ovulation happens earlier in this case? Wait, how does the cycle length affect the calculation? The cycle length is the number of days from the first day of one period to the first day of the next. If the cycle is 25 days, then ovulation would typically occur about 14 days before the next expected period. Let me check that again. For example, if the cycle is 28 days, ovulation is around day 14. So for a 25-day cycle, ovulation would be around day 11 (since 25 minus 14 is 11). Hmm, wait, no. Wait, the formula is that ovulation occurs approximately 14 days before the start of the next menstruation. So if the cycle is 25 days, the next period would be 25 days after the LMP. So ovulation would be at 25 - 14 = 11 days after the LMP. So the estimated ovulation date would be 11 days after the LMP. Since conception typically occurs around the time of ovulation, so the conception date would be around that day. The LMP given is February 8, 2024. Adding 11 days to that would give the estimated ovulation/conception date. Let me calculate that. Starting from February 8, adding 11 days: February 8 + 1 day is 9, then 10, 11, 12, 13, 14, 15, 16, 17, 18, 19. Wait, 8 + 11 days: 8 + 10 is 18, plus 1 more is 19. Let me double-check: 25-day cycle means next period starts on March 5 (since 2/8 plus 25 days: 28 days in February? Wait, wait, 2024 is a leap year. Wait, the LMP is 2/8/2024. Adding 25 days would bring the next period to March 5? Let me see: from 2/8 to 2/28 is 20 days (including the 8th?), no, wait, 2/8 to 2/28 is 20 days. Then from 2/28 to 3/5 is 5 days. Wait, maybe I should calculate the next period as LMP + 25 days. So 2/8 + 25 days. Let me do that. 2/8 plus 25 days. Let me count: 2/8 + 20 days is 2/28, then add 5 more days: 3/5. So the next period would be March 5, so ovulation is 14 days before that, which is 3/5 minus 14 days. 3/5 minus 14 days: 3/5 is March 5. Subtract 14 days: March 5 minus 1 week (7 days) is March 5 \u2212 7 = March 1. Then subtract another 7 days: March 1 \u2212 7 days is February 22. Wait, but that seems conflicting. Wait, perhaps my initial approach was wrong. Alternatively, maybe it\u2019s better to calculate ovulation as LMP + (cycle length \u2212 14) days. So if the cycle is 25 days, then ovulation is on day 25 \u2212 14 = 11 after LMP. So 2/8 + 11 days is 2/19. Let me confirm this. Another way: in a 25-day cycle, ovulation typically occurs around day 11, so adding 11 days to LMP gives the ovulation date. Therefore, conception is around that day. So 2/8 + 11 days is 2/19. So the answer should be 2/19/2024. I think that\u2019s correct. Let me check with another method. Suppose the LMP is 2/8, cycle length 25, so the next period starts on 3/5. Ovulation is 14 days before that, which is 3/5 minus 14 days. 3/5 minus 14 days is February 19 (because March 5 minus 1 week is March 1, then subtract another 7 days: March 1 minus 7 = February 22. Wait, no. Wait, March 5 minus 7 days is March 1. March 1 minus 7 days is February 22. So that would be 2/22? Wait, so that contradicts the previous method. Hmm, now I'm confused. Which is correct? Wait, maybe my calculation here is wrong. Let me count the days step by step. March 5 minus 14 days: Alternatively, maybe the formula is different. Let me think differently: the average ovulation time is about 10\u201316 days after the first day of the LMP. But in a 25-day cycle, ovulation typically occurs around day 11, so the conception date would be around that day.", "Ground Truth Answer": "02/22/2024", "Ground Truth Explanation": "The patient's estimated date of conception based on their last period is computed by adding to 2 weeks to the patient's last menstrual period date. The patient's last menstrual period was 02/08/2024. \nThe estimated date of conception after adding 2 weeks to the patient's last menstrual period date is 02-22-2024. ", "Result": "Incorrect"}
{"Row Number": 993, "Calculator Name": "Morphine Milligram Equivalents (MME) Calculator", "Calculator ID": "49", "Category": "dosage", "Note ID": "6", "Patient Note": "The patient takes 60 mg of OxyCODONE 1 time a day, 70 mg of HYDROmorphone 2 times a day, and 10 mg of Codeine 2 times a day.", "Question": "Based on the number of doses per day and the quantity of different doses, what is the patient's daily Morphine Miligram Equivalents (MME)?", "LLM Name": "BytedTsinghua-SIA/DAPO-Qwen-32B", "LLM Answer": "792", "LLM Explanation": "To calculate the Morphine Milligram Equivalents (MME) for the patient's medications, I will convert each medication to its MME and sum them up.\\n\\n1. OxyCODONE: The patient takes 60 mg once a day.\\n - Conversion factor for OxyCODONE to MME is 1.5.\\n - Daily MME for OxyCODONE = 60 mg * 1.5 = 90 mg MME.\\n\\n2. Hydromorphone: The patient takes 70 mg twice a day.\\n - Total daily dose = 70 mg * 2 = 140 mg.\\n - Conversion factor for Hydromorphone to MME is 5.\\n - Daily MME for Hydromorphone = 140 mg * 5 = 700 mg MME.\\n\\n3. Codeine: The patient takes 10 mg twice a day.\\n - Total daily dose = 10 mg * 2 = 20 mg.\\n - Conversion factor for Codeine to MME is 0.1.\\n - Daily MME for Codeine = 20 mg * 0.1 = 2 mg MME.\\n\\nNow, I will add up the MME from all three medications to get the total daily MME.\\nTotal MME = 90 mg MME (OxyCODONE) + 700 mg MME (Hydromorphone) + 2 mg MME (Codeine) = 792 mg MME.", "LLM Thinking": "Okay, so I need to calculate the Morphine Milligram Equival ents (MME) for this patient based on their current medications. Let me start by recalling what each of these opioids converts to in terms of MME. First, the patient is taking OxyCODONE 6 0 mg once a day, Hydrocodone 70 mg twice a day, and Codeine 10 mg twice a day. Wait, actually the note says OxyCODONE is 60 mg once daily , Hydromorphone 70 mg twice daily, and Codeine 10 mg twice daily. Right. I need to find the conversion factors for each of these opioids to M ME. I remember that different opioids have different potencies when converted to morph ine. Let me list out the conversion factors as per standard guidelines. Typically, the standard conversions are: - Oxycodone: 1 mg = 1.5 mg morphine - Hydrocodone: 1 mg = 1.5 mg morphine (I think) but wait, some sources say hydrocodone is 2.5x stronger than morphine? Hmm, maybe I should check. Wait, no, actually, hydrocodone is considered less potent than morph ine. The standard conversion is usually 1 mg hydrocodone = 1.5 mg morphine, similar to oxycodone. But I might be mixing this up with hydromorphone, which is much stronger. Hydromorphone is a different story. It's a full opioid agonist like morphine but has a higher potency . The conversion factor for Hydromorphone to morphine is 1 mg hydromorphone = 5 mg morphine. So each mg of hydromorphone counts as 5 mg M ME. Codeine is another one. Codeine is converted to morphine in the body, but its potency is lower. The standard conversion for codeine is 1 mg codeine = 0 .1 mg morphine. So that's a tenth. But wait, some sources might use 1 mg codeine = 0 .1 mg morphine, others might use 1 mg codeine = 0.2 mg morphine. I need to confirm. Let me think: codeine is about 1/10th as potent as morphine in terms of MME. So 1 mg code ine = 0.1 mg MME. Okay, so now I 'll break down each medication's total daily dose and multiply by their conversion factor , then sum them all up for the total MME. Starting with O xyCODONE: 60 mg once a day. The conversion factor is 1.5. So 60 mg * 1.5 = 90 mg MME per day. Next, Hydrocod one: 70 mg twice a day. Each dose is 7 0 mg, taken twice, so total is 70*2= 140 mg per day. The conversion factor is 1.5 , so 140 mg *1.5 = 210 mg MME. Then Codeine: 10 mg twice a day. Total daily dose is 20 mg. Conversion factor 0 .1, so 20 *0.1 = 2 mg MME. Let me double-check the calculations. For Oxy, 60*1.5=90. Hydrocodone 70*2 is 140, times 1.5 is 210. Codeine 10 *2=20, times 0.1 is 2. Wait, but I want to make sure about the conversion factors again. Let me verify: - Oxycodone to morphine: 1 :1.5, yes. - Hydrocodone: I think some sources say 1 mg hydrocodone = 1.5 mg morph ine. But other sources might say 1 mg hydrocodone = 1. 5 mg morphine, but I'm not entirely sure if that's the same as oxycodone. Alternatively, maybe it's 1 mg hydrocodone = 1. 5 mg morphine equivalent. Let me check my memory. For example, the CDC guidelines say that hydrocodone has an MME of 1.5. So 1 mg hydrocodone = 1.5 mg morphine. So that part is correct. Then hydromorphone is 1:5. Codeine is 1:0.1 or 0.2. I think it 's 0.1. Because codeine is metabolized to morphine , but at a slower rate. So 1 mg codeine = 0.1 mg morphine. Therefore, the calculation is correct. So 20 mg codeine would be 2 mg MME. Hmm. Let me cross-validate using another method. Let me see: - OxyCODONE: 60 mg/day *1.5 =90. - Hydrocodone: 70 mg *2 doses *1.5 = 70*2 =140*1.5=210. - Code ine: 10*2*0.1=2. Yes, that's correct. Yes, that's correct.", "Ground Truth Answer": "793", "Ground Truth Explanation": "The curent Morphine Milligram Equivalents (MME) is 0 MME per day.\nThe patient's dose of OxyCODONE is 60 mg. The patient takes 1 doses/day of OxyCODONE. This means that the patient takes 60 mg/dose OxyCODONE * 1 dose/day = 60 mg/day. To convert to mme/day of OxyCODONE, multiply the 60 mg/day by the mme conversion factor, 1.5 mme/mg, giving us 90.0 mme/day. Adding the mme/day of OxyCODONE to the total mme/day gives us 0 + 90.0 = 90.0 mme/day.\nThe patient's dose of HYDROmorphone is 70 mg. The patient takes 2 doses/day of HYDROmorphone. This means that the patient takes 70 mg/dose HYDROmorphone * 2 dose/day = 140 mg/day. To convert to mme/day of HYDROmorphone, multiply the 140 mg/day by the mme conversion factor, 5 mme/mg, giving us 700 mme/day. Adding the mme/day of HYDROmorphone to the total mme/day gives us 90.0 + 700 = 790.0 mme/day.\nThe patient's dose of Codeine is 10 mg. The patient takes 2 doses/day of Codeine. This means that the patient takes 10 mg/dose Codeine * 2 dose/day = 20 mg/day. To convert to mme/day of Codeine, multiply the 20 mg/day by the mme conversion factor, 0.15 mme/mg, giving us 3.0 mme/day. Adding the mme/day of Codeine to the total mme/day gives us 790.0 + 3.0 = 793.0 mme/day.\nThe patient's mme/day is 793.0 mme/day.", "Result": "Correct", "Thought Type": "ensembled_thought_without_answer", "Transferred Thoughts": "Okay, so I need to calculate the Morphine Milligram Equival ents (MME) for this patient based on their current medications. Let me start by recalling what each of these opioids converts to in terms of MME.\n\nFirst, the patient is taking OxyCODONE 6 0 mg once a day, Hydrocodone 70 mg twice a day, and Codeine 10 mg twice a day. Wait, actually the note says OxyCODONE is 60 mg once daily , Hydromorphone 70 mg twice daily, and Codeine 10 mg twice daily. Right. I need to find the conversion factors for each of these opioids to M ME.\n\nI remember that different opioids have different potencies when converted to morph ine. Let me list out the conversion factors as per standard guidelines. Typically, the standard conversions are:\n\n- Oxycodone: 1 mg = 1.5 mg morphine\n- Hydrocodone: 1 mg = 1.5 mg morphine (I think) but wait, some sources say hydrocodone is 2.5x stronger than morphine? Hmm, maybe I should check. Wait, no, actually, hydrocodone is considered less potent than morph ine. The standard conversion is usually 1 mg hydrocodone = 1.5 mg morphine, similar to oxycodone. But I might be mixing this up with hydromorphone, which is much stronger.\n\nHydromorphone is a different story. It's a full opioid agonist like morphine but has a higher potency . The conversion factor for Hydromorphone to morphine is 1 mg hydromorphone = 5 mg morphine. So each mg of hydromorphone counts as 5 mg M ME.\n\nCodeine is another one. Codeine is converted to morphine in the body, but its potency is lower. The standard conversion for codeine is 1 mg codeine = 0 .1 mg morphine. So that's a tenth. But wait, some sources might use 1 mg codeine = 0 .1 mg morphine, others might use 1 mg codeine = 0.2 mg morphine. I need to confirm. Let me think: codeine is about 1/10th as potent as morphine in terms of MME. So 1 mg code ine = 0.1 mg MME.\n\nOkay, so now I 'll break down each medication's total daily dose and multiply by their conversion factor , then sum them all up for the total MME.\n\nStarting with O xyCODONE: 60 mg once a day. The conversion factor is 1.5. So 60 mg * 1.5 = 90 mg MME per day.\n\nNext, Hydrocod one: 70 mg twice a day. Each dose is 7 0 mg, taken twice, so total is 70*2= 140 mg per day. The conversion factor is 1.5 , so 140 mg *1.5 = 210 mg MME.\n\nThen Codeine: 10 mg twice a day. Total daily dose is 20 mg. Conversion factor 0 .1, so 20 *0.1 = 2 mg MME.\n\nLet me double-check the calculations. For Oxy, 60*1.5=90. Hydrocodone 70*2 is 140, times 1.5 is 210. Codeine 10 *2=20, times 0.1 is 2. \n\nWait, but I want to make sure about the conversion factors again. Let me verify:\n\n- Oxycodone to morphine: 1 :1.5, yes.\n\n- Hydrocodone: I think some sources say 1 mg hydrocodone = 1.5 mg morph ine. But other sources might say 1 mg hydrocodone = 1. 5 mg morphine, but I'm not entirely sure if that's the same as oxycodone. Alternatively, maybe it's 1 mg hydrocodone = 1. 5 mg morphine equivalent. Let me check my memory. For example, the CDC guidelines say that hydrocodone has an MME of 1.5. So 1 mg hydrocodone = 1.5 mg morphine. So that part is correct. Then hydromorphone is 1:5. Codeine is 1:0.1 or 0.2. I think it 's 0.1. Because codeine is metabolized to morphine , but at a slower rate. So 1 mg codeine = 0.1 mg morphine. Therefore, the calculation is correct. So 20 mg codeine would be 2 mg MME.\n\nHmm. Let me cross-validate using another method. Let me see:\n\n- OxyCODONE: 60 mg/day *1.5 =90.\n\n- Hydrocodone: 70 mg *2 doses *1.5 = 70*2 =140*1.5=210.\n\n- Code ine: 10*2*0.1=2.\n\nYes, that's correct.\n\nYes, that's correct."}
